FHIR IG analytics| Package | noma.fhir.mpd |
| Resource Type | CodeSystem |
| Id | ATC_Cardiovascular_System.json |
| FHIR Version | R4 |
| Source | https://simplifier.net/resolve?scope=noma.fhir.mpd@2.0.0&canonical=https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22 |
| URL | https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22 |
| Status | active |
| Name | Anatomical Therapeutic Chemical classification system - Human - Cardiovascular system Examples |
| Content | complete |
No resources found
No resources found
No narrative content found in resource
FHIR
FHIRsmith{
"resourceType": "CodeSystem",
"id": "e104a7eb-e832-4d57-946d-d402b71ecc22",
"meta": {
"versionId": "1",
"lastUpdated": "2025-08-11T08:38:13.626+00:00"
},
"url": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"identifier": [
{
"system": "http://legemiddelverket.no/fhir/SAFEST/SafestCodeSystemID",
"value": "e104a7eb-e832-4d57-946d-d402b71ecc22"
},
{
"system": "http://legemiddelverket.no/fhir/SAFEST/ListID",
"value": "100000094240"
}
],
"name": "Anatomical Therapeutic Chemical classification system - Human - Cardiovascular system Examples",
"status": "active",
"content": "complete",
"property": [
{
"code": "parentATC",
"description": "Parent ATC",
"type": "Coding"
},
{
"code": "fromDate",
"description": "From Date",
"type": "Coding"
},
{
"code": "toDate",
"description": "To Date",
"type": "Coding"
},
{
"code": "previousVersion",
"description": "Previous Version",
"type": "Coding"
},
{
"code": "ATCCode",
"description": "ATC Code",
"type": "Coding"
},
{
"code": "internalCode",
"description": "Internal code",
"type": "Coding"
},
{
"code": "termIdRms",
"description": "RMS ID",
"type": "Coding"
},
{
"code": "internalTermStatus",
"description": "Status (internal)",
"type": "Coding"
},
{
"code": "sourceTermStatus",
"description": "Status (RMS)",
"type": "Coding"
}
],
"concept": [
{
"code": "C01DX16",
"display": "Nicorandil",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Nicorandil"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nikorandil"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DX",
"display": "Other vasodilators used in cardiac diseases"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DX16",
"display": "C01DX16"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DX16"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BA12",
"display": "Pravastatin, ezetimibe and fenofibrate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Pravastatin, ezetimibe and fenofibrate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Pravastatin, ezetimib og fenofibrat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10BA",
"display": "Combinations of various lipid modifying agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BA12",
"display": "C10BA12"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2021-11-08T00:00:00Z",
"display": "2021-11-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BA12"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03DA03",
"display": "Canrenone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Canrenone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kanrenon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03DA",
"display": "Aldosterone antagonists"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03DA03",
"display": "C03DA03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03DA03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DA08",
"display": "Isosorbide dinitrate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Isosorbide dinitrate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Isosorbiddinitrat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DA",
"display": "Organic nitrates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DA08",
"display": "C01DA08"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DA08"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BA13",
"display": "Pitavastatin and ezetimibe",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Pitavastatin and ezetimibe"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Pitavastatin og ezetimib"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10BA",
"display": "Combinations of various lipid modifying agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BA13",
"display": "C10BA13"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2024-11-19T00:00:00Z",
"display": "2024-11-19T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BA13"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02LG51",
"display": "Dihydralazine and diuretics, combinations with other drugs",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Dihydralazine and diuretics, combinations with other drugs"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Dihydralazin og diuretika, kombinasjoner med andre midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02LG",
"display": "Hydrazinophthalazine derivatives and diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02LG51",
"display": "C02LG51"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02LG51"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03BD",
"display": "Xanthine derivatives",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Xanthine derivatives"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Xantinderivater"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03B",
"display": "Low-ceiling diuretics, excl. thiazides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03BD",
"display": "C03BD"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03BD"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AX07",
"display": "Magnesium pyridoxal 5-phosphate glutamate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Magnesium pyridoxal 5-phosphate glutamate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Magnesium pyridoksal 5-fosfat glutamat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AX",
"display": "Other lipid modifying agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AX07",
"display": "C10AX07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AX07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07AA07",
"display": "Sotalol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Sotalol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Sotalol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07AA",
"display": "Beta blocking agents, non-selective"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07AA07",
"display": "C07AA07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07AA07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05BA04",
"display": "Pentosan polysulfate sodium",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Pentosan polysulfate sodium"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Pentosanpolysulfatnatrium"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05BA",
"display": "Heparins or heparinoids for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05BA04",
"display": "C05BA04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05BA04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01AC01",
"display": "G-strophanthin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "G-strophanthin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "G-Strofantin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01AC",
"display": "Strophantus glycosides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01AC01",
"display": "C01AC01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01AC01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07FB07",
"display": "Bisoprolol and amlodipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bisoprolol and amlodipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bisoprolol og amlodipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07FB",
"display": "Beta blocking agents and calcium channel blockers"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07FB07",
"display": "C07FB07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2011-01-01T00:00:00Z",
"display": "2011-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07FB07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02LK01",
"display": "Veratrum and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Veratrum and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Veratrum og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02LK",
"display": "Alkaloids, excl. rauwolfia, in combination with diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02LK01",
"display": "C02LK01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02LK01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07AB04",
"display": "Acebutolol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Acebutolol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Acebutolol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07AB",
"display": "Beta blocking agents, selective"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07AB04",
"display": "C07AB04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07AB04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08CA03",
"display": "Isradipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Isradipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Isradipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08CA",
"display": "Dihydropyridine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08CA03",
"display": "C08CA03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08CA03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05BB",
"display": "Sclerosing agents for local injection",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Sclerosing agents for local injection"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Skleroserende midler til lokal injeksjon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05B",
"display": "Antivaricose therapy"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05BB",
"display": "C05BB"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05BB"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AX11",
"display": "Bencyclane",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bencyclane"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bensyklan"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04AX",
"display": "Other peripheral vasodilators"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AX11",
"display": "C04AX11"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AX11"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DA09",
"display": "Trolnitrate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Trolnitrate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Trolnitrat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DA",
"display": "Organic nitrates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DA09",
"display": "C01DA09"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DA09"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09BA12",
"display": "Delapril and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Delapril and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Delapril og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09BA",
"display": "ACE inhibitors and diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09BA12",
"display": "C09BA12"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09BA12"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07CB",
"display": "Beta blocking agents, selective, and other diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Beta blocking agents, selective, and other diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Betablokkere, selektive, og andre diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07C",
"display": "Beta blocking agents and other diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07CB",
"display": "C07CB"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07CB"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07FX06",
"display": "Carvedilol and ivabradine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Carvedilol and ivabradine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Karvedilol og ivabradin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07FX",
"display": "Beta blocking agents, other combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07FX06",
"display": "C07FX06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2016-02-09T00:00:00Z",
"display": "2016-02-09T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07FX06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BA06",
"display": "Rosuvastatin and ezetimibe",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Rosuvastatin and ezetimibe"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Rosuvastatin og ezetimib"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10BA",
"display": "Combinations of various lipid modifying agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BA06",
"display": "C10BA06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2013-07-15T00:00:00Z",
"display": "2013-07-15T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BA06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05A",
"display": "Agents for treatment of hemorrhoids and anal fissures for topical use",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Agents for treatment of hemorrhoids and anal fissures for topical use"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Midler til behandling av hemoroider og anale fissurer til topikal bruk"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05",
"display": "Vasoprotectives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05A",
"display": "C05A"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05A"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09BX07",
"display": "Zofenopril and nebivolol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Zofenopril and nebivolol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Zofenopril og nebivolol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09BX",
"display": "ACE inhibitors, other combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09BX07",
"display": "C09BX07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2023-11-15T00:00:00Z",
"display": "2023-11-15T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09BX07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09AA",
"display": "ACE inhibitors, plain",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "ACE inhibitors, plain"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "ACE-hemmere, usammensatte"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09A",
"display": "ACE inhibitors, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09AA",
"display": "C09AA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09AA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AB05",
"display": "Fenofibrate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Fenofibrate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fenofibrat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AB",
"display": "Fibrates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AB05",
"display": "C10AB05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AB05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CA06",
"display": "Phenylephrine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Phenylephrine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fenylefrin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CA",
"display": "Adrenergic and dopaminergic agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CA06",
"display": "C01CA06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CA06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05BX",
"display": "Other sclerosing agents",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other sclerosing agents"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre skleroserende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05B",
"display": "Antivaricose therapy"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05BX",
"display": "C05BX"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05BX"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BX01",
"display": "Simvastatin and acetylsalicylic acid",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Simvastatin and acetylsalicylic acid"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Simvastatin og acetylsalisylsyre"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10BX",
"display": "Lipid modifying agents in combination with other drugs"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BX01",
"display": "C10BX01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BX01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08DB01",
"display": "Diltiazem",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Diltiazem"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Diltiazem"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08DB",
"display": "Benzothiazepine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08DB01",
"display": "C08DB01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08DB01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BX09",
"display": "Rosuvastatin and amlodipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Rosuvastatin and amlodipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Rosuvastatin og amlodipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10BX",
"display": "Lipid modifying agents in combination with other drugs"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BX09",
"display": "C10BX09"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2014-02-20T00:00:00Z",
"display": "2014-02-20T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BX09"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09DX",
"display": "Angiotensin II receptor blockers (ARBs), other combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Angiotensin II receptor blockers (ARBs), other combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Angiotensin II reseptorblokkere (ARBs), andre kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09D",
"display": "Angiotensin II receptor blockers (ARBs), combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09DX",
"display": "C09DX"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2010-01-01T00:00:00Z",
"display": "2010-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09DX"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09CA",
"display": "Angiotensin II receptor blockers (ARBs), plain",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Angiotensin II receptor blockers (ARBs), plain"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Angiotensin II reseptorblokkere (ARBs), usammensatte"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09C",
"display": "Angiotensin II receptor blockers (ARBs), plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09CA",
"display": "C09CA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09CA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DA05",
"display": "Pentaerithrityl tetranitrate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Pentaerithrityl tetranitrate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Pentaeritrityltetranitrat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DA",
"display": "Organic nitrates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DA05",
"display": "C01DA05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DA05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09BB04",
"display": "Perindopril and amlodipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Perindopril and amlodipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Perindopril og amlodipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09BB",
"display": "ACE inhibitors and calcium channel blockers"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09BB04",
"display": "C09BB04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2009-03-20T00:00:00Z",
"display": "2009-03-20T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09BB04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05CA03",
"display": "Diosmin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Diosmin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Diosmin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05CA",
"display": "Bioflavonoids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05CA03",
"display": "C05CA03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05CA03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07CA23",
"display": "Penbutolol and other diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Penbutolol and other diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Penbutolol og andre diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07CA",
"display": "Beta blocking agents, non-selective, and other diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07CA23",
"display": "C07CA23"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07CA23"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05AD01",
"display": "Lidocaine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Lidocaine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Lidokain"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05AD",
"display": "Local anesthetics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05AD01",
"display": "C05AD01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05AD01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07FB13",
"display": "Metoprolol and amlodipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Metoprolol and amlodipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Metoprolol og amlodipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07FB",
"display": "Beta blocking agents and calcium channel blockers"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07FB13",
"display": "C07FB13"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2017-06-14T00:00:00Z",
"display": "2017-06-14T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07FB13"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DX11",
"display": "Trapidil",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Trapidil"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Trapidil"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DX",
"display": "Other vasodilators used in cardiac diseases"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DX11",
"display": "C01DX11"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DX11"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CX07",
"display": "Xamoterol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Xamoterol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Xamoterol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CX",
"display": "Other cardiac stimulants"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CX07",
"display": "C01CX07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CX07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BX",
"display": "Lipid modifying agents in combination with other drugs",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Lipid modifying agents in combination with other drugs"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Lipidmodifiserende midler i kombinasjon med andre legemidler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10B",
"display": "Lipid modifying agents, combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BX",
"display": "C10BX"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BX"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03XA02",
"display": "Conivaptan",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Conivaptan"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Konivaptan"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03XA",
"display": "Vasopressin antagonists"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03XA02",
"display": "C03XA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2009-03-20T00:00:00Z",
"display": "2009-03-20T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03XA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C",
"display": "Cardiovascular system",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Cardiovascular system"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Hjerte og kretsløp"
}
],
"property": [
{
"code": "ATCCode",
"valueCoding": {
"code": "C",
"display": "C"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07BA05",
"display": "Propranolol and thiazides",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Propranolol and thiazides"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Propranolol og tiazider"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07BA",
"display": "Beta blocking agents, non-selective, and thiazides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07BA05",
"display": "C07BA05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07BA05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CE01",
"display": "Amrinone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Amrinone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Amrinon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CE",
"display": "Phosphodiesterase inhibitors"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CE01",
"display": "C01CE01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CE01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02LK",
"display": "Alkaloids, excl. rauwolfia, in combination with diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Alkaloids, excl. rauwolfia, in combination with diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Alkaloider, ekskl. rauwolfia, kombinasjoner med diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02L",
"display": "Antihypertensives and diuretics in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02LK",
"display": "C02LK"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02LK"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05XX",
"display": "Other vasoprotectives",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other vasoprotectives"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre vasoprotektorer"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05X",
"display": "Other vasoprotectives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05XX",
"display": "C05XX"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2023-10-30T00:00:00Z",
"display": "2023-10-30T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05XX"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01EB13",
"display": "Acadesine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Acadesine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Akadesin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01EB",
"display": "Other cardiac preparations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01EB13",
"display": "C01EB13"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01EB13"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07FB",
"display": "Beta blocking agents and calcium channel blockers",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Beta blocking agents and calcium channel blockers"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Betablokkere og kalsiumkanalblokkere"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07F",
"display": "Beta blocking agents, other combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07FB",
"display": "C07FB"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07FB"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CA03",
"display": "Norepinephrine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Norepinephrine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Noradrenalin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CA",
"display": "Adrenergic and dopaminergic agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CA03",
"display": "C01CA03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CA03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02BA01",
"display": "Trimetaphan",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Trimetaphan"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Trimetafan"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02BA",
"display": "Sulfonium derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02BA01",
"display": "C02BA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02BA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07CB02",
"display": "Metoprolol and other diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Metoprolol and other diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Metoprolol og andre diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07CB",
"display": "Beta blocking agents, selective, and other diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07CB02",
"display": "C07CB02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07CB02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02LA01",
"display": "Reserpine and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Reserpine and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Reserpin og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02LA",
"display": "Rauwolfia alkaloids and diuretics in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02LA01",
"display": "C02LA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02LA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AC",
"display": "Nicotinic acid and derivatives",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Nicotinic acid and derivatives"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nikotinsyre og derivater"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04A",
"display": "Peripheral vasodilators"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AC",
"display": "C04AC"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AC"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02AA04",
"display": "Rauwolfia alkaloids, whole root",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Rauwolfia alkaloids, whole root"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Rauwolfiaalkaloider, hel rot"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02AA",
"display": "Rauwolfia alkaloids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02AA04",
"display": "C02AA04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02AA04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AE51",
"display": "Ergoloid mesylates, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ergoloid mesylates, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ergoloidmesylat, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04AE",
"display": "Ergot alkaloids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AE51",
"display": "C04AE51"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AE51"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AA05",
"display": "Atorvastatin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Atorvastatin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Atorvastatin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AA",
"display": "HMG CoA reductase inhibitors"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AA05",
"display": "C10AA05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AA05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01BD05",
"display": "Ibutilide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ibutilide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ibutilid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01BD",
"display": "Antiarrhythmics, class III"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01BD05",
"display": "C01BD05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01BD05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AD01",
"display": "Niceritrol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Niceritrol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nikeritrol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AD",
"display": "Nicotinic acid and derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AD01",
"display": "C10AD01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AD01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AX24",
"display": "Visnadine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Visnadine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Visnadin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04AX",
"display": "Other peripheral vasodilators"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AX24",
"display": "C04AX24"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AX24"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02LA04",
"display": "Methoserpidine and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Methoserpidine and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Metoserpidin og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02LA",
"display": "Rauwolfia alkaloids and diuretics in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02LA04",
"display": "C02LA04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02LA04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07AB08",
"display": "Celiprolol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Celiprolol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Celiprolol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07AB",
"display": "Beta blocking agents, selective"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07AB08",
"display": "C07AB08"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07AB08"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BX17",
"display": "Rosuvastatin and ramipril",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Rosuvastatin and ramipril"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Rosuvastatin og ramipril"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10BX",
"display": "Lipid modifying agents in combination with other drugs"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BX17",
"display": "C10BX17"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2019-12-15T00:00:00Z",
"display": "2019-12-15T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BX17"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02AC04",
"display": "Tolonidine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Tolonidine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tolonidin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02AC",
"display": "Imidazoline receptor agonists"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02AC04",
"display": "C02AC04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02AC04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AX17",
"display": "Vinburnine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Vinburnine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Vinburnin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04AX",
"display": "Other peripheral vasodilators"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AX17",
"display": "C04AX17"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AX17"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08CA07",
"display": "Nisoldipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Nisoldipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nisoldipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08CA",
"display": "Dihydropyridine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08CA07",
"display": "C08CA07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08CA07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05AA10",
"display": "Fluocinolone acetonide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Fluocinolone acetonide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fluocinolonacetonid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05AA",
"display": "Corticosteroids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05AA10",
"display": "C05AA10"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05AA10"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CA17",
"display": "Midodrine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Midodrine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Midodrin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CA",
"display": "Adrenergic and dopaminergic agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CA17",
"display": "C01CA17"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CA17"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01EB24",
"display": "Mavacamten",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Mavacamten"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Mavakamten"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01EB",
"display": "Other cardiac preparations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01EB24",
"display": "C01EB24"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2022-05-05T00:00:00Z",
"display": "2022-05-05T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01EB24"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03AA04",
"display": "Chlorothiazide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Chlorothiazide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Klortiazid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03AA",
"display": "Thiazides, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03AA04",
"display": "C03AA04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03AA04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09BX05",
"display": "Ramipril and bisoprolol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ramipril and bisoprolol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ramipril og bisoprolol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09BX",
"display": "ACE inhibitors, other combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09BX05",
"display": "C09BX05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2020-10-12T00:00:00Z",
"display": "2020-10-12T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09BX05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05CA04",
"display": "Troxerutin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Troxerutin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Trokserutin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05CA",
"display": "Bioflavonoids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05CA04",
"display": "C05CA04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05CA04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03CA03",
"display": "Piretanide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Piretanide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Piretanid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03CA",
"display": "Sulfonamides, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03CA03",
"display": "C03CA03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03CA03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DX12",
"display": "Molsidomine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Molsidomine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Molsidomin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DX",
"display": "Other vasodilators used in cardiac diseases"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DX12",
"display": "C01DX12"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DX12"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02KD01",
"display": "Ketanserin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ketanserin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ketanserin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02KD",
"display": "Serotonin antagonists"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02KD01",
"display": "C02KD01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02KD01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02LN",
"display": "Serotonin antagonists and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Serotonin antagonists and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Serotonin antagonister og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02L",
"display": "Antihypertensives and diuretics in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02LN",
"display": "C02LN"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02LN"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09DX01",
"display": "Valsartan, amlodipine and hydrochlorothiazide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Valsartan, amlodipine and hydrochlorothiazide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Valsartan, amlodipin og hydroklortiazid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09DX",
"display": "Angiotensin II receptor blockers (ARBs), other combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09DX01",
"display": "C09DX01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2010-01-01T00:00:00Z",
"display": "2010-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09DX01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DX53",
"display": "Oxyfedrine, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Oxyfedrine, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Oksyfedrin, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DX",
"display": "Other vasodilators used in cardiac diseases"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DX53",
"display": "C01DX53"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DX53"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AX11",
"display": "Mipomersen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Mipomersen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Mipomersen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AX",
"display": "Other lipid modifying agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AX11",
"display": "C10AX11"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2011-08-17T00:00:00Z",
"display": "2011-08-17T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AX11"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AE02",
"display": "Nicergoline",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Nicergoline"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nikergolin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04AE",
"display": "Ergot alkaloids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AE02",
"display": "C04AE02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AE02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BX14",
"display": "Rosuvastatin, amlodipine and perindopril",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Rosuvastatin, amlodipine and perindopril"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Rosuvastatin, amlodipin og perindopril"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10BX",
"display": "Lipid modifying agents in combination with other drugs"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BX14",
"display": "C10BX14"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2017-01-10T00:00:00Z",
"display": "2017-01-10T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BX14"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07AA17",
"display": "Bopindolol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bopindolol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bopindolol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07AA",
"display": "Beta blocking agents, non-selective"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07AA17",
"display": "C07AA17"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07AA17"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07BB12",
"display": "Nebivolol and thiazides",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Nebivolol and thiazides"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nebivolol og tiazider"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07BB",
"display": "Beta blocking agents, selective, and thiazides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07BB12",
"display": "C07BB12"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2011-01-01T00:00:00Z",
"display": "2011-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07BB12"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05CX03",
"display": "Hippocastani semen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Hippocastani semen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Hippocastani semen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05CX",
"display": "Other capillary stabilizing agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05CX03",
"display": "C05CX03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2012-01-01T00:00:00Z",
"display": "2012-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05CX03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09BB10",
"display": "Trandolapril and verapamil",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Trandolapril and verapamil"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Trandolapril og verapamil"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09BB",
"display": "ACE inhibitors and calcium channel blockers"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09BB10",
"display": "C09BB10"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09BB10"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09BA01",
"display": "Captopril and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Captopril and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kaptopril og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09BA",
"display": "ACE inhibitors and diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09BA01",
"display": "C09BA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09BA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07FX05",
"display": "Metoprolol and ivabradine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Metoprolol and ivabradine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Metoprolol og ivabradin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07FX",
"display": "Beta blocking agents, other combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07FX05",
"display": "C07FX05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2016-02-09T00:00:00Z",
"display": "2016-02-09T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07FX05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01BC04",
"display": "Flecainide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Flecainide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Flekainid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01BC",
"display": "Antiarrhythmics, class Ic"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01BC04",
"display": "C01BC04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01BC04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07FB03",
"display": "Atenolol and nifedipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Atenolol and nifedipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Atenolol og nifedipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07FB",
"display": "Beta blocking agents and calcium channel blockers"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07FB03",
"display": "C07FB03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07FB03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01BD07",
"display": "Dronedarone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Dronedarone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Dronedaron"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01BD",
"display": "Antiarrhythmics, class III"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01BD07",
"display": "C01BD07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2010-02-04T00:00:00Z",
"display": "2010-02-04T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01BD07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08CA55",
"display": "Nifedipine, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Nifedipine, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nifedipin, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08CA",
"display": "Dihydropyridine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08CA55",
"display": "C08CA55"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08CA55"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02DB",
"display": "Hydrazinophthalazine derivatives",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Hydrazinophthalazine derivatives"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Hydrazinoftalazinderivater"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02D",
"display": "Arteriolar smooth muscle, agents acting on"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02DB",
"display": "C02DB"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02DB"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08CA17",
"display": "Levamlodipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Levamlodipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Levamlodipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08CA",
"display": "Dihydropyridine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08CA17",
"display": "C08CA17"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2021-03-04T00:00:00Z",
"display": "2021-03-04T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08CA17"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09DB",
"display": "Angiotensin II receptor blockers (ARBs) and calcium channel blockers",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Angiotensin II receptor blockers (ARBs) and calcium channel blockers"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Angiotensin II reseptorblokkere (ARBs) og kalsiumkanal blokkere"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09D",
"display": "Angiotensin II receptor blockers (ARBs), combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09DB",
"display": "C09DB"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09DB"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02AB01",
"display": "Methyldopa (levorotatory)",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Methyldopa (levorotatory)"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Metyldopa (venstredreiende)"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02AB",
"display": "Methyldopa"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02AB01",
"display": "C02AB01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02AB01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05CA51",
"display": "Rutoside, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Rutoside, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Rutosid, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05CA",
"display": "Bioflavonoids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05CA51",
"display": "C05CA51"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05CA51"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AB07",
"display": "Ronifibrate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ronifibrate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ronifibrat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AB",
"display": "Fibrates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AB07",
"display": "C10AB07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AB07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BA07",
"display": "Rosuvastatin and omega-3 fatty acids",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Rosuvastatin and omega-3 fatty acids"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Rosuvastatin og omega-3 fettsyrer"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10BA",
"display": "Combinations of various lipid modifying agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BA07",
"display": "C10BA07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2019-04-09T00:00:00Z",
"display": "2019-04-09T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BA07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02DC",
"display": "Pyrimidine derivatives",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Pyrimidine derivatives"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Pyrimidinderivater"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02D",
"display": "Arteriolar smooth muscle, agents acting on"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02DC",
"display": "C02DC"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02DC"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BX11",
"display": "Atorvastatin, amlodipine and perindopril",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Atorvastatin, amlodipine and perindopril"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Atorvastatin, amlodipin og perindopril"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10BX",
"display": "Lipid modifying agents in combination with other drugs"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BX11",
"display": "C10BX11"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2015-07-06T00:00:00Z",
"display": "2015-07-06T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BX11"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03CC02",
"display": "Tienilic acid",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Tienilic acid"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tienilsyre"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03CC",
"display": "Aryloxyacetic acid derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03CC02",
"display": "C03CC02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03CC02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08GA",
"display": "Calcium channel blockers and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Calcium channel blockers and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kalsiumantagonister og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08G",
"display": "Calcium channel blockers and diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08GA",
"display": "C08GA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08GA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01AA03",
"display": "Digitalis leaves",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Digitalis leaves"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Digitalisblad"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01AA",
"display": "Digitalis glycosides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01AA03",
"display": "C01AA03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01AA03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01AA06",
"display": "Lanatoside C",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Lanatoside C"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Lanatosid C"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01AA",
"display": "Digitalis glycosides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01AA06",
"display": "C01AA06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01AA06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07CA03",
"display": "Pindolol and other diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Pindolol and other diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Pindolol og andre diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07CA",
"display": "Beta blocking agents, non-selective, and other diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07CA03",
"display": "C07CA03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07CA03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07AB",
"display": "Beta blocking agents, selective",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Beta blocking agents, selective"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Betablokkere, selektive"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07A",
"display": "Beta blocking agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07AB",
"display": "C07AB"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07AB"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03AA13",
"display": "Mebutizide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Mebutizide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Mebutizid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03AA",
"display": "Thiazides, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03AA13",
"display": "C03AA13"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03AA13"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CA10",
"display": "Methoxamine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Methoxamine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Metoksamin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CA",
"display": "Adrenergic and dopaminergic agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CA10",
"display": "C01CA10"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CA10"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02CA03",
"display": "Trimazosin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Trimazosin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Trimazosin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02CA",
"display": "Alpha-adrenoreceptor antagonists"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02CA03",
"display": "C02CA03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02CA03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03BA11",
"display": "Indapamide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Indapamide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Indapamid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03BA",
"display": "Sulfonamides, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03BA11",
"display": "C03BA11"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03BA11"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05BA02",
"display": "Sodium apolate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Sodium apolate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Natriumapolat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05BA",
"display": "Heparins or heparinoids for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05BA02",
"display": "C05BA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05BA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BX04",
"display": "Simvastatin, acetylsalicylic acid and ramipril",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Simvastatin, acetylsalicylic acid and ramipril"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Simvastatin, acetylsalisylsyre og ramipril"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10BX",
"display": "Lipid modifying agents in combination with other drugs"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BX04",
"display": "C10BX04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2011-01-01T00:00:00Z",
"display": "2011-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BX04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03CA01",
"display": "Furosemide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Furosemide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Furosemid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03CA",
"display": "Sulfonamides, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03CA01",
"display": "C03CA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03CA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09CA03",
"display": "Valsartan",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Valsartan"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Valsartan"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09CA",
"display": "Angiotensin II receptor blockers (ARBs), plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09CA03",
"display": "C09CA03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09CA03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09DA",
"display": "Angiotensin II receptor blockers (ARBs) and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Angiotensin II receptor blockers (ARBs) and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Angiotensin II reseptorblokkere (ARBs) og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09D",
"display": "Angiotensin II receptor blockers (ARBs), combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09DA",
"display": "C09DA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09DA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AD",
"display": "Nicotinic acid and derivatives",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Nicotinic acid and derivatives"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nikotinsyre og derivater"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10A",
"display": "Lipid modifying agents, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AD",
"display": "C10AD"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AD"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03AA05",
"display": "Polythiazide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Polythiazide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Polytiazid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03AA",
"display": "Thiazides, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03AA05",
"display": "C03AA05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03AA05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07AB05",
"display": "Betaxolol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Betaxolol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Betaksolol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07AB",
"display": "Beta blocking agents, selective"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07AB05",
"display": "C07AB05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07AB05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DA",
"display": "Organic nitrates",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Organic nitrates"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nitrater"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01D",
"display": "Vasodilatators used in cardiac disease"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DA",
"display": "C01DA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01EB17",
"display": "Ivabradine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ivabradine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ivabradin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01EB",
"display": "Other cardiac preparations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01EB17",
"display": "C01EB17"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2005-11-11T00:00:00Z",
"display": "2005-11-11T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01EB17"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09BA",
"display": "ACE inhibitors and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "ACE inhibitors and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "ACE-hemmere og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09B",
"display": "ACE inhibitors, combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09BA",
"display": "C09BA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09BA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02",
"display": "Antihypertensives",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Antihypertensives"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Antihypertensiva"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C",
"display": "Cardiovascular system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02",
"display": "C02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05BA01",
"display": "Organo-heparinoid",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Organo-heparinoid"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Organo-heparinoid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05BA",
"display": "Heparins or heparinoids for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05BA01",
"display": "C05BA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05BA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AC04",
"display": "Colesevelam",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Colesevelam"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kolesevelam"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AC",
"display": "Bile acid sequestrants"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AC04",
"display": "C10AC04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2004-04-21T00:00:00Z",
"display": "2004-04-21T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AC04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02CC07",
"display": "Guanoxabenz",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Guanoxabenz"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Guanoksabenz"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02CC",
"display": "Guanidine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02CC07",
"display": "C02CC07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02CC07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02CC05",
"display": "Guanoclor",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Guanoclor"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Guanoklor"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02CC",
"display": "Guanidine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02CC05",
"display": "C02CC05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02CC05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02AC01",
"display": "Clonidine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Clonidine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Klonidin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02AC",
"display": "Imidazoline receptor agonists"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02AC01",
"display": "C02AC01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02AC01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08CA08",
"display": "Nitrendipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Nitrendipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nitrendipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08CA",
"display": "Dihydropyridine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08CA08",
"display": "C08CA08"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08CA08"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03EB",
"display": "High-ceiling diuretics and potassium-sparing agents",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "High-ceiling diuretics and potassium-sparing agents"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "High-ceiling diuretika og kaliumsparende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03E",
"display": "Diuretics and potassium-sparing agents in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03EB",
"display": "C03EB"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03EB"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07DB",
"display": "Beta blocking agents, selective, thiazides and other diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Beta blocking agents, selective, thiazides and other diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Betablokkere, selektive, tiazider andre diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07D",
"display": "Beta blocking agents, selective, thiazides and other diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07DB",
"display": "C07DB"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07DB"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05AD",
"display": "Local anesthetics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Local anesthetics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Lokalanestetika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05A",
"display": "Agents for treatment of hemorrhoids and anal fissures for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05AD",
"display": "C05AD"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05AD"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02KD",
"display": "Serotonin antagonists",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Serotonin antagonists"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Serotonin antagonister"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02K",
"display": "Other antihypertensives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02KD",
"display": "C02KD"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02KD"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03A",
"display": "Low-ceiling diuretics, thiazides",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Low-ceiling diuretics, thiazides"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Low-ceiling diuretika, tiazider"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03",
"display": "Diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03A",
"display": "C03A"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03A"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02LE01",
"display": "Prazosin and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Prazosin and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Prazosin og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02LE",
"display": "Alpha-adrenoreceptor antagonists and diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02LE01",
"display": "C02LE01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02LE01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07CB03",
"display": "Atenolol and other diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Atenolol and other diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Atenolol og andre diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07CB",
"display": "Beta blocking agents, selective, and other diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07CB03",
"display": "C07CB03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07CB03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09BX",
"display": "ACE inhibitors, other combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "ACE inhibitors, other combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "ACE-hemmere, andre kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09B",
"display": "ACE inhibitors, combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09BX",
"display": "C09BX"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2013-12-10T00:00:00Z",
"display": "2013-12-10T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09BX"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05AB",
"display": "Antibiotics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Antibiotics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Antibiotika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05A",
"display": "Agents for treatment of hemorrhoids and anal fissures for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05AB",
"display": "C05AB"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05AB"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01EB25",
"display": "Acoramidis",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Acoramidis"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Akoramidis"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01EB",
"display": "Other cardiac preparations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01EB25",
"display": "C01EB25"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2025-01-01T00:00:00Z",
"display": "2025-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01EB25"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02AA57",
"display": "Bietaserpine, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bietaserpine, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bietaserpin, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02AA",
"display": "Rauwolfia alkaloids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02AA57",
"display": "C02AA57"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02AA57"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09BB07",
"display": "Ramipril and amlodipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ramipril and amlodipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ramipril og amlodipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09BB",
"display": "ACE inhibitors and calcium channel blockers"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09BB07",
"display": "C09BB07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2012-01-01T00:00:00Z",
"display": "2012-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09BB07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05CX02",
"display": "Naftazone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Naftazone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Naftazon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05CX",
"display": "Other capillary stabilizing agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05CX02",
"display": "C05CX02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2011-01-01T00:00:00Z",
"display": "2011-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05CX02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AC",
"display": "Bile acid sequestrants",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bile acid sequestrants"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Midler som øker utskillelsen av gallesyre"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10A",
"display": "Lipid modifying agents, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AC",
"display": "C10AC"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AC"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07AB13",
"display": "Talinolol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Talinolol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Talinolol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07AB",
"display": "Beta blocking agents, selective"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07AB13",
"display": "C07AB13"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07AB13"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08G",
"display": "Calcium channel blockers and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Calcium channel blockers and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kalsiumantagonister og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08",
"display": "Calcium channel blockers"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08G",
"display": "C08G"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08G"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07F",
"display": "Beta blocking agents, other combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Beta blocking agents, other combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Betablokkere, andre kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07",
"display": "Beta blocking agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07F",
"display": "C07F"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07F"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CA01",
"display": "Etilefrine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Etilefrine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Etilefrin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CA",
"display": "Adrenergic and dopaminergic agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CA01",
"display": "C01CA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03BB",
"display": "Sulfonamides and potassium in combination",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Sulfonamides and potassium in combination"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Sulfonamider og kalium i kombinasjon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03B",
"display": "Low-ceiling diuretics, excl. thiazides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03BB",
"display": "C03BB"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03BB"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05AA12",
"display": "Triamcinolone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Triamcinolone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Triamcinolon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05AA",
"display": "Corticosteroids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05AA12",
"display": "C05AA12"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2011-01-01T00:00:00Z",
"display": "2011-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05AA12"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08CA02",
"display": "Felodipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Felodipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Felodipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08CA",
"display": "Dihydropyridine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08CA02",
"display": "C08CA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08CA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01AX02",
"display": "Peruvoside",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Peruvoside"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Peruvosid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01AX",
"display": "Other cardiac glycosides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01AX02",
"display": "C01AX02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01AX02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DA57",
"display": "Propatylnitrate, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Propatylnitrate, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Propatylnitrat, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DA",
"display": "Organic nitrates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DA57",
"display": "C01DA57"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DA57"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02KA",
"display": "Alkaloids, excl. rauwolfia",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Alkaloids, excl. rauwolfia"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Alkaloider, ekskl. rauwolfia"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02K",
"display": "Other antihypertensives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02KA",
"display": "C02KA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02KA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09DA02",
"display": "Eprosartan and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Eprosartan and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Eprosartan og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09DA",
"display": "Angiotensin II receptor blockers (ARBs) and diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09DA02",
"display": "C09DA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2003-12-10T00:00:00Z",
"display": "2003-12-10T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09DA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AC03",
"display": "Inositol nicotinate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Inositol nicotinate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Inositolnikotinat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04AC",
"display": "Nicotinic acid and derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AC03",
"display": "C04AC03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AC03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09CA08",
"display": "Olmesartan medoxomil",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Olmesartan medoxomil"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Olmesartanmedoksomil"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09CA",
"display": "Angiotensin II receptor blockers (ARBs), plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09CA08",
"display": "C09CA08"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2004-08-13T00:00:00Z",
"display": "2004-08-13T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09CA08"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09BB12",
"display": "Delapril and manidipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Delapril and manidipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Delapril og manidipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09BB",
"display": "ACE inhibitors and calcium channel blockers"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09BB12",
"display": "C09BB12"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09BB12"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03AA",
"display": "Thiazides, plain",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Thiazides, plain"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tiazider, usammensatte"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03A",
"display": "Low-ceiling diuretics, thiazides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03AA",
"display": "C03AA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03AA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DX18",
"display": "Linsidomine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Linsidomine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Linsidomin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DX",
"display": "Other vasodilators used in cardiac diseases"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DX18",
"display": "C01DX18"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DX18"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05XX01",
"display": "Beperminogene perplasmid",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Beperminogene perplasmid"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Beperminogenperplasmid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05XX",
"display": "Other vasoprotectives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05XX01",
"display": "C05XX01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2023-12-05T00:00:00Z",
"display": "2023-12-05T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05XX01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05AE02",
"display": "Isosorbide dinitrate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Isosorbide dinitrate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Isosorbiddinitrat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05AE",
"display": "Muscle relaxants"
}
},
{
"code": "previousVersion",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/f5a60497-f1c5-4163-ad34-a3c614d2f6b4",
"code": "D03AX08",
"display": "Isosorbide dinitrate"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05AE02",
"display": "C05AE02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2008-01-01T00:00:00Z",
"display": "2008-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05AE02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AA07",
"display": "Rosuvastatin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Rosuvastatin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Rosuvastatin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AA",
"display": "HMG CoA reductase inhibitors"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AA07",
"display": "C10AA07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AA07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09XA01",
"display": "Remikiren",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Remikiren"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Remikiren"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09XA",
"display": "Renin-inhibitors"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09XA01",
"display": "C09XA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09XA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07FX03",
"display": "Metoprolol and acetylsalisylic acid",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Metoprolol and acetylsalisylic acid"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Metoprolol og acetylsalisylsyre"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07FX",
"display": "Beta blocking agents, other combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07FX03",
"display": "C07FX03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07FX03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BA01",
"display": "Lovastatin and nicotinic acid",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Lovastatin and nicotinic acid"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Lovastatin og nikotinsyre"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10BA",
"display": "Combinations of various lipid modifying agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BA01",
"display": "C10BA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02LA02",
"display": "Rescinnamine and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Rescinnamine and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Reskinnamin og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02LA",
"display": "Rauwolfia alkaloids and diuretics in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02LA02",
"display": "C02LA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02LA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AB06",
"display": "Simfibrate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Simfibrate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Simfibrat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AB",
"display": "Fibrates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AB06",
"display": "C10AB06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AB06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01AA05",
"display": "Digoxin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Digoxin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Digoksin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01AA",
"display": "Digitalis glycosides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01AA05",
"display": "C01AA05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01AA05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01D",
"display": "Vasodilatators used in cardiac disease",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Vasodilatators used in cardiac disease"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kardilaterende midler ved hjertesykdommer"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01",
"display": "Cardiac therapy"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01D",
"display": "C01D"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01D"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07AB01",
"display": "Practolol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Practolol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Praktolol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07AB",
"display": "Beta blocking agents, selective"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07AB01",
"display": "C07AB01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07AB01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08EA02",
"display": "Bepridil",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bepridil"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bepridil"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08EA",
"display": "Phenylalkylamine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08EA02",
"display": "C08EA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08EA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AC01",
"display": "Nicotinic acid",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Nicotinic acid"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nikotinsyre"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04AC",
"display": "Nicotinic acid and derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AC01",
"display": "C04AC01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AC01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01EB19",
"display": "Icatibant",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Icatibant"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ikatibant"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01EB",
"display": "Other cardiac preparations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01EB19",
"display": "C01EB19"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2009-01-22T00:00:00Z",
"display": "2009-01-22T00:00:00Z"
}
},
{
"code": "toDate",
"valueCoding": {
"code": "2012-01-01T00:00:00Z",
"display": "2012-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01EB19"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Slettet",
"display": "Slettet"
}
}
]
},
{
"code": "C10AX14",
"display": "Alirocumab",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Alirocumab"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Alirokumab"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AX",
"display": "Other lipid modifying agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AX14",
"display": "C10AX14"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2016-02-01T00:00:00Z",
"display": "2016-02-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AX14"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07BB52",
"display": "Metoprolol and thiazides, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Metoprolol and thiazides, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Metoprolol og tiazider, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07BB",
"display": "Beta blocking agents, selective, and thiazides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07BB52",
"display": "C07BB52"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07BB52"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05BB05",
"display": "Phenol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Phenol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fenol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05BB",
"display": "Sclerosing agents for local injection"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05BB05",
"display": "C05BB05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05BB05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01EB09",
"display": "Ubidecarenone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ubidecarenone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ubidekarenon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01EB",
"display": "Other cardiac preparations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01EB09",
"display": "C01EB09"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01EB09"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02AA05",
"display": "Deserpidine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Deserpidine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Deserpidin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02AA",
"display": "Rauwolfia alkaloids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02AA05",
"display": "C02AA05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02AA05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03DB",
"display": "Other potassium-sparing agents",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other potassium-sparing agents"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre kaliumsparende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03D",
"display": "Aldosterone antagonists and other potassium-sparing agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03DB",
"display": "C03DB"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03DB"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05X",
"display": "Other vasoprotectives",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other vasoprotectives"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre vasoprotektorer"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05",
"display": "Vasoprotectives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05X",
"display": "C05X"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2023-10-30T00:00:00Z",
"display": "2023-10-30T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05X"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DX22",
"display": "Vericiguat",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Vericiguat"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Verisiguat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DX",
"display": "Other vasodilators used in cardiac diseases"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DX22",
"display": "C01DX22"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2020-10-15T00:00:00Z",
"display": "2020-10-15T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DX22"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07FB02",
"display": "Metoprolol and felodipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Metoprolol and felodipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Metoprolol og felodipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07FB",
"display": "Beta blocking agents and calcium channel blockers"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07FB02",
"display": "C07FB02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07FB02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AB01",
"display": "Phentolamine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Phentolamine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fentolamin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04AB",
"display": "Imidazoline derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AB01",
"display": "C04AB01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AB01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01EB18",
"display": "Ranolazine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ranolazine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ranolazin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01EB",
"display": "Other cardiac preparations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01EB18",
"display": "C01EB18"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01EB18"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09BB03",
"display": "Lisinopril and amlodipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Lisinopril and amlodipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Lisinopril og amlodipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09BB",
"display": "ACE inhibitors and calcium channel blockers"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09BB03",
"display": "C09BB03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2010-01-01T00:00:00Z",
"display": "2010-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09BB03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03E",
"display": "Diuretics and potassium-sparing agents in combination",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Diuretics and potassium-sparing agents in combination"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Diuretika i kombinasjoner med kaliumsparende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03",
"display": "Diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03E",
"display": "C03E"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03E"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02LG",
"display": "Hydrazinophthalazine derivatives and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Hydrazinophthalazine derivatives and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Hydrazinoftalazinderivater og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02L",
"display": "Antihypertensives and diuretics in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02LG",
"display": "C02LG"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02LG"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01A",
"display": "Cardiac glycosides",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Cardiac glycosides"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Hjerteglykosider"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01",
"display": "Cardiac therapy"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01A",
"display": "C01A"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01A"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CA22",
"display": "Arbutamine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Arbutamine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Arbutamin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CA",
"display": "Adrenergic and dopaminergic agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CA22",
"display": "C01CA22"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CA22"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AX16",
"display": "Inclisiran",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Inclisiran"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Inklisiran"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AX",
"display": "Other lipid modifying agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AX16",
"display": "C10AX16"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2020-10-12T00:00:00Z",
"display": "2020-10-12T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AX16"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AX21",
"display": "Naftidrofuryl",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Naftidrofuryl"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Naftidrofuryl"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04AX",
"display": "Other peripheral vasodilators"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AX21",
"display": "C04AX21"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AX21"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02DB01",
"display": "Dihydralazine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Dihydralazine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Dihydralazin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02DB",
"display": "Hydrazinophthalazine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02DB01",
"display": "C02DB01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02DB01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05AX06",
"display": "Phenylephrine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Phenylephrine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fenylefrin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05AX",
"display": "Other agents for treatment of hemorrhoids and anal fissures for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05AX06",
"display": "C05AX06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2023-12-05T00:00:00Z",
"display": "2023-12-05T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05AX06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BX21",
"display": "Rosuvastatin and perindopril",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Rosuvastatin and perindopril"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Rosuvastatin og perindopril"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10BX",
"display": "Lipid modifying agents in combination with other drugs"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BX21",
"display": "C10BX21"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2023-11-15T00:00:00Z",
"display": "2023-11-15T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BX21"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09BB05",
"display": "Ramipril and felodipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ramipril and felodipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ramipril og felodipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09BB",
"display": "ACE inhibitors and calcium channel blockers"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09BB05",
"display": "C09BB05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09BB05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09BX02",
"display": "Perindopril and bisoprolol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Perindopril and bisoprolol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Perindopril og bisoprolol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09BX",
"display": "ACE inhibitors, other combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09BX02",
"display": "C09BX02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2015-07-06T00:00:00Z",
"display": "2015-07-06T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09BX02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01BD03",
"display": "Bunaftine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bunaftine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bunaftin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01BD",
"display": "Antiarrhythmics, class III"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01BD03",
"display": "C01BD03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01BD03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07BA07",
"display": "Sotalol and thiazides",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Sotalol and thiazides"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Sotalol og tiazider"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07BA",
"display": "Beta blocking agents, non-selective, and thiazides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07BA07",
"display": "C07BA07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07BA07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01EA",
"display": "Prostaglandins",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Prostaglandins"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Prostaglandiner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01E",
"display": "Other cardiac preparations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01EA",
"display": "C01EA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01EA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09DB01",
"display": "Valsartan and amlodipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Valsartan and amlodipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Valsartan og amlodipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09DB",
"display": "Angiotensin II receptor blockers (ARBs) and calcium channel blockers"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09DB01",
"display": "C09DB01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2006-08-14T00:00:00Z",
"display": "2006-08-14T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09DB01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02AA52",
"display": "Reserpine, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Reserpine, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Reserpin, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02AA",
"display": "Rauwolfia alkaloids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02AA52",
"display": "C02AA52"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02AA52"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01BA",
"display": "Antiarrhythmics, class Ia",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Antiarrhythmics, class Ia"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Antiarytmika, klasse Ia"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01B",
"display": "Antiarrhythmics, class I and III"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01BA",
"display": "C01BA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01BA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CA11",
"display": "Mephentermine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Mephentermine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Mefentermin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CA",
"display": "Adrenergic and dopaminergic agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CA11",
"display": "C01CA11"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CA11"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08D",
"display": "Selective calcium channel blockers with direct cardiac effects",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Selective calcium channel blockers with direct cardiac effects"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Selektive kalsiumantagonister med direkte virkning på hjertet"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08",
"display": "Calcium channel blockers"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08D",
"display": "C08D"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08D"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09XA53",
"display": "Aliskiren and amlodipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Aliskiren and amlodipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Aliskiren og amlodipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09XA",
"display": "Renin-inhibitors"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09XA53",
"display": "C09XA53"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2011-01-01T00:00:00Z",
"display": "2011-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09XA53"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AA06",
"display": "Cerivastatin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Cerivastatin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Cerivastatin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AA",
"display": "HMG CoA reductase inhibitors"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AA06",
"display": "C10AA06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AA06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09BA09",
"display": "Fosinopril and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Fosinopril and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fosinopril og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09BA",
"display": "ACE inhibitors and diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09BA09",
"display": "C09BA09"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09BA09"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03BA02",
"display": "Quinethazone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Quinethazone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kinetazon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03BA",
"display": "Sulfonamides, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03BA02",
"display": "C03BA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03BA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09AA12",
"display": "Delapril",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Delapril"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Delapril"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09AA",
"display": "ACE inhibitors, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09AA12",
"display": "C09AA12"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09AA12"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07BB02",
"display": "Metoprolol and thiazides",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Metoprolol and thiazides"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Metoprolol og tiazider"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07BB",
"display": "Beta blocking agents, selective, and thiazides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07BB02",
"display": "C07BB02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07BB02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05BX51",
"display": "Calcium dobesilate, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Calcium dobesilate, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kalsiumdobesilat, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05BX",
"display": "Other sclerosing agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05BX51",
"display": "C05BX51"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05BX51"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03AB01",
"display": "Bendroflumethiazide and potassium",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bendroflumethiazide and potassium"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bendroflumetiazid og kalium"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03AB",
"display": "Thiazides and potassium in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03AB01",
"display": "C03AB01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03AB01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BA08",
"display": "Atorvastatin and omega-3 fatty acids",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Atorvastatin and omega-3 fatty acids"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Atorvastatin og omega-3 fettsyrer"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10BA",
"display": "Combinations of various lipid modifying agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BA08",
"display": "C10BA08"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2019-04-09T00:00:00Z",
"display": "2019-04-09T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BA08"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AD02",
"display": "Xantinol nicotinate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Xantinol nicotinate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Xantinolnikotinat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04AD",
"display": "Purine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AD02",
"display": "C04AD02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AD02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01EB03",
"display": "Indometacin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Indometacin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Indometacin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01EB",
"display": "Other cardiac preparations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01EB03",
"display": "C01EB03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01EB03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09",
"display": "Agents acting on the renin-angiotensin system",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Agents acting on the renin-angiotensin system"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Midler med virkning på renin-angiotensinsystemet"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C",
"display": "Cardiovascular system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09",
"display": "C09"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AC07",
"display": "Ciclonicate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ciclonicate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ciklonikat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04AC",
"display": "Nicotinic acid and derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AC07",
"display": "C04AC07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AC07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DA04",
"display": "Methylpropylpropanediol dinitrate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Methylpropylpropanediol dinitrate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Metylpropylpropandioldinitrat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DA",
"display": "Organic nitrates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DA04",
"display": "C01DA04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DA04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02CA06",
"display": "Urapidil",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Urapidil"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Urapidil"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02CA",
"display": "Alpha-adrenoreceptor antagonists"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02CA06",
"display": "C02CA06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02CA06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AB03",
"display": "Aluminium clofibrate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Aluminium clofibrate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Aluminiumklofibrat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AB",
"display": "Fibrates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AB03",
"display": "C10AB03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AB03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09DA06",
"display": "Candesartan and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Candesartan and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kandesartan og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09DA",
"display": "Angiotensin II receptor blockers (ARBs) and diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09DA06",
"display": "C09DA06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09DA06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AX19",
"display": "Suloctidil",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Suloctidil"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Suloktidil"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04AX",
"display": "Other peripheral vasodilators"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AX19",
"display": "C04AX19"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AX19"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DA52",
"display": "Glyceryl trinitrate, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Glyceryl trinitrate, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Glyseryltrinitrat, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DA",
"display": "Organic nitrates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DA52",
"display": "C01DA52"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DA52"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BX05",
"display": "Rosuvastatin and acetylsalisylic acid",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Rosuvastatin and acetylsalisylic acid"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Rosuvastatin og acetylsalisylsyre"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10BX",
"display": "Lipid modifying agents in combination with other drugs"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BX05",
"display": "C10BX05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2013-12-10T00:00:00Z",
"display": "2013-12-10T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BX05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08DA",
"display": "Phenylalkylamine derivatives",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Phenylalkylamine derivatives"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fenylalkylaminderivater"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08D",
"display": "Selective calcium channel blockers with direct cardiac effects"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08DA",
"display": "C08DA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08DA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03XA",
"display": "Vasopressin antagonists",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Vasopressin antagonists"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Vasopressinantagonister"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03X",
"display": "Other diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03XA",
"display": "C03XA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2009-03-20T00:00:00Z",
"display": "2009-03-20T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03XA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01BC03",
"display": "Propafenone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Propafenone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Propafenon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01BC",
"display": "Antiarrhythmics, class Ic"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01BC03",
"display": "C01BC03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01BC03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01BA02",
"display": "Procainamide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Procainamide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Prokainamid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01BA",
"display": "Antiarrhythmics, class Ia"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01BA02",
"display": "C01BA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01BA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AA",
"display": "HMG CoA reductase inhibitors",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "HMG CoA reductase inhibitors"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "HMG-CoA-reduktasehemmere"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10A",
"display": "Lipid modifying agents, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AA",
"display": "C10AA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BX15",
"display": "Atorvastatin and perindopril",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Atorvastatin and perindopril"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Atorvastatin og perindopril"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10BX",
"display": "Lipid modifying agents in combination with other drugs"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BX15",
"display": "C10BX15"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2017-12-01T00:00:00Z",
"display": "2017-12-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BX15"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01EB06",
"display": "Fosfocreatine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Fosfocreatine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fosfokreatin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01EB",
"display": "Other cardiac preparations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01EB06",
"display": "C01EB06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01EB06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01AC",
"display": "Strophantus glycosides",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Strophantus glycosides"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Strofantusglykosider"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01A",
"display": "Cardiac glycosides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01AC",
"display": "C01AC"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01AC"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02DG01",
"display": "Pinacidil",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Pinacidil"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Pinacidil"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02DG",
"display": "Guanidine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02DG01",
"display": "C02DG01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02DG01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05BA51",
"display": "Heparinoid, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Heparinoid, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Heparinoid, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05BA",
"display": "Heparins or heparinoids for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05BA51",
"display": "C05BA51"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05BA51"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AB",
"display": "Fibrates",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Fibrates"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fibrater"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10A",
"display": "Lipid modifying agents, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AB",
"display": "C10AB"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AB"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DA58",
"display": "Isosorbide dinitrate, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Isosorbide dinitrate, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Isosorbiddinitrat, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DA",
"display": "Organic nitrates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DA58",
"display": "C01DA58"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DA58"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09D",
"display": "Angiotensin II receptor blockers (ARBs), combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Angiotensin II receptor blockers (ARBs), combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Angiotensin II reseptorblokkere (ARBs), kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09",
"display": "Agents acting on the renin-angiotensin system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09D",
"display": "C09D"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09D"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BX12",
"display": "Atorvastatin, Acetylsalisylsyre and Perindopril",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Atorvastatin, Acetylsalisylsyre and Perindopril"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Atorvastatin, Acetylsalisylsyre og Perindopril"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10BX",
"display": "Lipid modifying agents in combination with other drugs"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BX12",
"display": "C10BX12"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2016-12-20T00:00:00Z",
"display": "2016-12-20T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BX12"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05AX",
"display": "Other agents for treatment of hemorrhoids and anal fissures for topical use",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other agents for treatment of hemorrhoids and anal fissures for topical use"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre topikale midler for behandling mot hemorrider og analfissurer"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05A",
"display": "Agents for treatment of hemorrhoids and anal fissures for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05AX",
"display": "C05AX"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05AX"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09BA07",
"display": "Benazepril and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Benazepril and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Benazepril og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09BA",
"display": "ACE inhibitors and diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09BA07",
"display": "C09BA07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09BA07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CA30",
"display": "Combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CA",
"display": "Adrenergic and dopaminergic agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CA30",
"display": "C01CA30"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CA30"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DA20",
"display": "Organic nitrates in combination",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Organic nitrates in combination"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nitrater i kombinasjon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DA",
"display": "Organic nitrates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DA20",
"display": "C01DA20"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DA20"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02LC01",
"display": "Clonidine and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Clonidine and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Klonidin og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02LC",
"display": "Imidazoline receptor agonists in combination with diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02LC01",
"display": "C02LC01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02LC01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09AA11",
"display": "Spirapril",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Spirapril"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Spirapril"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09AA",
"display": "ACE inhibitors, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09AA11",
"display": "C09AA11"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09AA11"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02LG02",
"display": "Hydralazine and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Hydralazine and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Hydralazin og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02LG",
"display": "Hydrazinophthalazine derivatives and diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02LG02",
"display": "C02LG02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02LG02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05CA54",
"display": "Troxerutin, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Troxerutin, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Trokserutin, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05CA",
"display": "Bioflavonoids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05CA54",
"display": "C05CA54"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05CA54"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AX12",
"display": "Lomitapide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Lomitapide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Lomitapid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AX",
"display": "Other lipid modifying agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AX12",
"display": "C10AX12"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2013-01-28T00:00:00Z",
"display": "2013-01-28T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AX12"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09DX05",
"display": "Valsartan and nebivolol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Valsartan and nebivolol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Valsartan og nebivolol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09DX",
"display": "Angiotensin II receptor blockers (ARBs), other combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09DX05",
"display": "C09DX05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2018-07-10T00:00:00Z",
"display": "2018-07-10T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09DX05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01AX",
"display": "Other cardiac glycosides",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other cardiac glycosides"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre hjerteglykosider"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01A",
"display": "Cardiac glycosides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01AX",
"display": "C01AX"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01AX"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AD05",
"display": "Nicotinyl alcohol (pyridylcarbinol)",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Nicotinyl alcohol (pyridylcarbinol)"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nikotinylalkohol (pyridylkarbinol)"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AD",
"display": "Nicotinic acid and derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AD05",
"display": "C10AD05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AD05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09CA04",
"display": "Irbesartan",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Irbesartan"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Irbesartan"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09CA",
"display": "Angiotensin II receptor blockers (ARBs), plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09CA04",
"display": "C09CA04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09CA04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CA09",
"display": "Metaraminol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Metaraminol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Metaraminol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CA",
"display": "Adrenergic and dopaminergic agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CA09",
"display": "C01CA09"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CA09"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07CA02",
"display": "Oxprenolol and other diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Oxprenolol and other diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Oksprenolol og andre diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07CA",
"display": "Beta blocking agents, non-selective, and other diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07CA02",
"display": "C07CA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07CA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08CX",
"display": "Other selective calcium channel blockers with mainly vascular effects",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other selective calcium channel blockers with mainly vascular effects"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre selektive kalsiumantagonister med primært vaskulær virkning"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08C",
"display": "Selective calcium channel blockers with mainly vascular effects"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08CX",
"display": "C08CX"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08CX"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08CA04",
"display": "Nicardipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Nicardipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nikardipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08CA",
"display": "Dihydropyridine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08CA04",
"display": "C08CA04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08CA04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AX10",
"display": "Moxisylyte",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Moxisylyte"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Moksisylyt"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04AX",
"display": "Other peripheral vasodilators"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AX10",
"display": "C04AX10"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AX10"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AX15",
"display": "Bempedoic acid",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bempedoic acid"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bempedoinsyre"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AX",
"display": "Other lipid modifying agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AX15",
"display": "C10AX15"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2019-12-19T00:00:00Z",
"display": "2019-12-19T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AX15"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09XA52",
"display": "Aliskiren and hydrochlorothiazide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Aliskiren and hydrochlorothiazide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Aliskiren og hydroklortiazid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09XA",
"display": "Renin-inhibitors"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09XA52",
"display": "C09XA52"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2008-01-01T00:00:00Z",
"display": "2008-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09XA52"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03BA",
"display": "Sulfonamides, plain",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Sulfonamides, plain"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Sulfonamider, usammensatte"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03B",
"display": "Low-ceiling diuretics, excl. thiazides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03BA",
"display": "C03BA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03BA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02LX",
"display": "Other antihypertensives and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other antihypertensives and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre antihypertensiva og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02L",
"display": "Antihypertensives and diuretics in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02LX",
"display": "C02LX"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02LX"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02LG01",
"display": "Dihydralazine and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Dihydralazine and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Dihydralazin og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02LG",
"display": "Hydrazinophthalazine derivatives and diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02LG01",
"display": "C02LG01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02LG01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03",
"display": "Diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C",
"display": "Cardiovascular system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03",
"display": "C03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09CA05",
"display": "Tasosartan",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Tasosartan"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tasosartan"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09CA",
"display": "Angiotensin II receptor blockers (ARBs), plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09CA05",
"display": "C09CA05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09CA05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07FX04",
"display": "Bisoprolol and acetylsalicylic acid",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bisoprolol and acetylsalicylic acid"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bisoprolol og acetylsalisylsyre"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07FX",
"display": "Beta blocking agents, other combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07FX04",
"display": "C07FX04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2010-01-01T00:00:00Z",
"display": "2010-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07FX04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03BA13",
"display": "Fenquizone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Fenquizone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fenkvison"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03BA",
"display": "Sulfonamides, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03BA13",
"display": "C03BA13"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03BA13"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01BD06",
"display": "Tedisamil",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Tedisamil"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tedisamil"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01BD",
"display": "Antiarrhythmics, class III"
}
},
{
"code": "previousVersion",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01EB12",
"display": "Tedisamil"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01BD06",
"display": "C01BD06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2009-01-01T00:00:00Z",
"display": "2009-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01BD06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07B",
"display": "Beta blocking agents and thiazider",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Beta blocking agents and thiazider"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Betablokkere og tiazider"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07",
"display": "Beta blocking agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07B",
"display": "C07B"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07B"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09DB05",
"display": "Irbesartan and amlodipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Irbesartan and amlodipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Irbesartan og amlodipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09DB",
"display": "Angiotensin II receptor blockers (ARBs) and calcium channel blockers"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09DB05",
"display": "C09DB05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2011-01-01T00:00:00Z",
"display": "2011-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09DB05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BX02",
"display": "Pravastatin and acetylsalicylic acid",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Pravastatin and acetylsalicylic acid"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Pravastatin og acetylsalisylsyre"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10BX",
"display": "Lipid modifying agents in combination with other drugs"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BX02",
"display": "C10BX02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BX02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07AG",
"display": "Alpha and beta blocking agents",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Alpha and beta blocking agents"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Alfa- og betablokkere"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07A",
"display": "Beta blocking agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07AG",
"display": "C07AG"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07AG"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05AD02",
"display": "Tetracaine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Tetracaine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tetrakain"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05AD",
"display": "Local anesthetics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05AD02",
"display": "C05AD02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05AD02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02K",
"display": "Other antihypertensives",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other antihypertensives"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre antihypertensiva"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02",
"display": "Antihypertensives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02K",
"display": "C02K"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02K"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05AD03",
"display": "Benzocaine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Benzocaine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Benzokain"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05AD",
"display": "Local anesthetics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05AD03",
"display": "C05AD03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05AD03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03AB06",
"display": "Trichlormethiazide and potassium",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Trichlormethiazide and potassium"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Triklormetiazid og kalium"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03AB",
"display": "Thiazides and potassium in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03AB06",
"display": "C03AB06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03AB06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01AB",
"display": "Scilla glycosides",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Scilla glycosides"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Scillaglykosider"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01A",
"display": "Cardiac glycosides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01AB",
"display": "C01AB"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01AB"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BX08",
"display": "Atorvastatin and acetylsalicylic acid",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Atorvastatin and acetylsalicylic acid"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Atorvastatin og acetylsalisylsyre"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10BX",
"display": "Lipid modifying agents in combination with other drugs"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BX08",
"display": "C10BX08"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2014-02-20T00:00:00Z",
"display": "2014-02-20T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BX08"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09BA03",
"display": "Lisinopril and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Lisinopril and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Lisinopril og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09BA",
"display": "ACE inhibitors and diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09BA03",
"display": "C09BA03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09BA03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AX28",
"display": "Ifenprodil",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ifenprodil"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ifenprodil"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04AX",
"display": "Other peripheral vasodilators"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AX28",
"display": "C04AX28"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AX28"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09DA07",
"display": "Telmisartan and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Telmisartan and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Telmisartan og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09DA",
"display": "Angiotensin II receptor blockers (ARBs) and diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09DA07",
"display": "C09DA07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2003-02-12T00:00:00Z",
"display": "2003-02-12T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09DA07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CX10",
"display": "Omecamtiv mecarbil",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Omecamtiv mecarbil"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Omekamtivmekarbil"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CX",
"display": "Other cardiac stimulants"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CX10",
"display": "C01CX10"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2023-12-05T00:00:00Z",
"display": "2023-12-05T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CX10"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CA21",
"display": "Cafedrine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Cafedrine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kafedrin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CA",
"display": "Adrenergic and dopaminergic agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CA21",
"display": "C01CA21"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CA21"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03BB03",
"display": "Clopamide and potassium",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Clopamide and potassium"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Klopamid og kalium"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03BB",
"display": "Sulfonamides and potassium in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03BB03",
"display": "C03BB03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03BB03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03BB07",
"display": "Clofenamide and potassium",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Clofenamide and potassium"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Klofenamid og kalium"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03BB",
"display": "Sulfonamides and potassium in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03BB07",
"display": "C03BB07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03BB07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09CA01",
"display": "Losartan",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Losartan"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Losartan"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09CA",
"display": "Angiotensin II receptor blockers (ARBs), plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09CA01",
"display": "C09CA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09CA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08EX01",
"display": "Lidoflazine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Lidoflazine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Lidoflazin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08EX",
"display": "Other non-selective calcium channel blockers"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08EX01",
"display": "C08EX01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08EX01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03AH01",
"display": "Chlorothiazide, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Chlorothiazide, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Klortiazid, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03AH",
"display": "Thiazides, combinations with psycholeptics and/or analgesics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03AH01",
"display": "C03AH01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03AH01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CA27",
"display": "Droxidopa",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Droxidopa"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Droksidopa"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CA",
"display": "Adrenergic and dopaminergic agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CA27",
"display": "C01CA27"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2015-07-06T00:00:00Z",
"display": "2015-07-06T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CA27"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09BA02",
"display": "Enalapril and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Enalapril and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Enalapril og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09BA",
"display": "ACE inhibitors and diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09BA02",
"display": "C09BA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09BA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07AA27",
"display": "Cloranolol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Cloranolol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kloranolol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07AA",
"display": "Beta blocking agents, non-selective"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07AA27",
"display": "C07AA27"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07AA27"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02LA09",
"display": "Syrosingopine and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Syrosingopine and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Syrosingopin og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02LA",
"display": "Rauwolfia alkaloids and diuretics in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02LA09",
"display": "C02LA09"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02LA09"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05CA",
"display": "Bioflavonoids",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bioflavonoids"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bioflavonoider"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05C",
"display": "Capillary stabilizing agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05CA",
"display": "C05CA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05CA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01EB11",
"display": "Tiracizine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Tiracizine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tiracizin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01EB",
"display": "Other cardiac preparations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01EB11",
"display": "C01EB11"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01EB11"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09DB09",
"display": "Fimasartan and amlodipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Fimasartan and amlodipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fimasartan og amlodipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09DB",
"display": "Angiotensin II receptor blockers (ARBs) and calcium channel blockers"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09DB09",
"display": "C09DB09"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2019-04-09T00:00:00Z",
"display": "2019-04-09T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09DB09"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AX",
"display": "Other peripheral vasodilators",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other peripheral vasodilators"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre perifere kardilaterende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04A",
"display": "Peripheral vasodilators"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AX",
"display": "C04AX"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AX"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AX27",
"display": "Cinepazide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Cinepazide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Cinepazid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04AX",
"display": "Other peripheral vasodilators"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AX27",
"display": "C04AX27"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AX27"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09XA54",
"display": "Aliskiren, amlodipine and hydrochlorothiazide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Aliskiren, amlodipine and hydrochlorothiazide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Aliskiren, amlodipin og hydroklortiazid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09XA",
"display": "Renin-inhibitors"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09XA54",
"display": "C09XA54"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2011-01-01T00:00:00Z",
"display": "2011-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09XA54"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09BX06",
"display": "Perindopril, bisoprolol, amlodipine and indapamide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Perindopril, bisoprolol, amlodipine and indapamide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Perindopril, bisoprolol, amlodipin og indapamid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09BX",
"display": "ACE inhibitors, other combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09BX06",
"display": "C09BX06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2023-12-05T00:00:00Z",
"display": "2023-12-05T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09BX06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03BD01",
"display": "Theobromine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Theobromine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Teobromin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03BD",
"display": "Xanthine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03BD01",
"display": "C03BD01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03BD01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CA",
"display": "Adrenergic and dopaminergic agents",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Adrenergic and dopaminergic agents"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Adrenerge og dopaminerge midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01C",
"display": "Cardiac stimulants excl. cardiac glycosides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CA",
"display": "C01CA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02KX52",
"display": "Ambrisentan and tadalafil",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ambrisentan and tadalafil"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ambrisentan og tadalafil"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02KX",
"display": "Antihypertensives for pulmonary arterial hypertension"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02KX52",
"display": "C02KX52"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2018-07-10T00:00:00Z",
"display": "2018-07-10T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02KX52"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BA03",
"display": "Pravastatin and fenofibrate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Pravastatin and fenofibrate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Pravastatin og fenofibrat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10BA",
"display": "Combinations of various lipid modifying agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BA03",
"display": "C10BA03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2010-01-01T00:00:00Z",
"display": "2010-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BA03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01BG07",
"display": "Cibenzoline",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Cibenzoline"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Cibenzolin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01BG",
"display": "Other antiarrhythmics, class I and III"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01BG07",
"display": "C01BG07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01BG07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03EA04",
"display": "Altizide and potassium-sparing agents",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Altizide and potassium-sparing agents"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Altizid og kaliumsparende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03EA",
"display": "Low-ceiling diuretics and potassium-sparing agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03EA04",
"display": "C03EA04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03EA04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09DA01",
"display": "Losartan and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Losartan and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Losartan og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09DA",
"display": "Angiotensin II receptor blockers (ARBs) and diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09DA01",
"display": "C09DA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09DA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01EB23",
"display": "Tiazotic acid",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Tiazotic acid"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tiazotsyre"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01EB",
"display": "Other cardiac preparations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01EB23",
"display": "C01EB23"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2016-02-10T00:00:00Z",
"display": "2016-02-10T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01EB23"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BX13",
"display": "Rosuvastatin, perindopril and indapamide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Rosuvastatin, perindopril and indapamide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Rosuvastatin, perindopril og indapamid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10BX",
"display": "Lipid modifying agents in combination with other drugs"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BX13",
"display": "C10BX13"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2017-01-10T00:00:00Z",
"display": "2017-01-10T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BX13"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BX03",
"display": "Atorvastatin and amlodipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Atorvastatin and amlodipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Atorvastatin og amlodipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10BX",
"display": "Lipid modifying agents in combination with other drugs"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BX03",
"display": "C10BX03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BX03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03EA03",
"display": "Epitizide and potassium-sparing agents",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Epitizide and potassium-sparing agents"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Epitizid og kaliumsparende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03EA",
"display": "Low-ceiling diuretics and potassium-sparing agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03EA03",
"display": "C03EA03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03EA03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05AX05",
"display": "Tribenoside",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Tribenoside"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tribenosid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05AX",
"display": "Other agents for treatment of hemorrhoids and anal fissures for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05AX05",
"display": "C05AX05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05AX05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02AA03",
"display": "Combinations of rauwolfia alkaloids",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Combinations of rauwolfia alkaloids"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Rauwolfiaalkaloider i blanding"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02AA",
"display": "Rauwolfia alkaloids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02AA03",
"display": "C02AA03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02AA03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DX06",
"display": "Hexobendine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Hexobendine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Heksobendin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DX",
"display": "Other vasodilators used in cardiac diseases"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DX06",
"display": "C01DX06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DX06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09CA02",
"display": "Eprosartan",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Eprosartan"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Eprosartan"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09CA",
"display": "Angiotensin II receptor blockers (ARBs), plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09CA02",
"display": "C09CA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09CA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09BA15",
"display": "Zofenopril and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Zofenopril and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Zofenopril og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09BA",
"display": "ACE inhibitors and diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09BA15",
"display": "C09BA15"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2006-05-31T00:00:00Z",
"display": "2006-05-31T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09BA15"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01BA51",
"display": "Quinidine, combinations excl. psycholeptics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Quinidine, combinations excl. psycholeptics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kinidin, kombinasjoner ekskl. psykoleptika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01BA",
"display": "Antiarrhythmics, class Ia"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01BA51",
"display": "C01BA51"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01BA51"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03EA07",
"display": "Cyclopenthiazide and potassium-sparing agents",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Cyclopenthiazide and potassium-sparing agents"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Cyklopentiazid og kaliumsparende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03EA",
"display": "Low-ceiling diuretics and potassium-sparing agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03EA07",
"display": "C03EA07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03EA07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01EB15",
"display": "Trimetazidine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Trimetazidine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Trimetazidin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01EB",
"display": "Other cardiac preparations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01EB15",
"display": "C01EB15"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01EB15"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02CA01",
"display": "Prazosin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Prazosin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Prazosin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02CA",
"display": "Alpha-adrenoreceptor antagonists"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02CA01",
"display": "C02CA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02CA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AX04",
"display": "Benfluorex",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Benfluorex"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Benfluoreks"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AX",
"display": "Other lipid modifying agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AX04",
"display": "C10AX04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "toDate",
"valueCoding": {
"code": "2009-01-01T00:00:00Z",
"display": "2009-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AX04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Slettet",
"display": "Slettet"
}
}
]
},
{
"code": "C07DB01",
"display": "Atenolol, thiazides and other diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Atenolol, thiazides and other diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Atenolol, tiazider og andre diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07DB",
"display": "Beta blocking agents, selective, thiazides and other diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07DB01",
"display": "C07DB01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07DB01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07AA06",
"display": "Timolol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Timolol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Timolol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07AA",
"display": "Beta blocking agents, non-selective"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07AA06",
"display": "C07AA06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07AA06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01AB01",
"display": "Proscillaridin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Proscillaridin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Proskillaridin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01AB",
"display": "Scilla glycosides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01AB01",
"display": "C01AB01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01AB01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05",
"display": "Vasoprotectives",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Vasoprotectives"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Vasoprotektorer"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C",
"display": "Cardiovascular system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05",
"display": "C05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01BG",
"display": "Other antiarrhythmics, class I and III",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other antiarrhythmics, class I and III"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre antiarytmika, klasse I og III"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01B",
"display": "Antiarrhythmics, class I and III"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01BG",
"display": "C01BG"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01BG"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09DA03",
"display": "Valsartan and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Valsartan and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Valsartan og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09DA",
"display": "Angiotensin II receptor blockers (ARBs) and diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09DA03",
"display": "C09DA03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09DA03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02LG73",
"display": "Picodralazine and diuretics, combinations with psycholeptics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Picodralazine and diuretics, combinations with psycholeptics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Pikodralazin og diuretika, kombinasjoner med psykoleptika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02LG",
"display": "Hydrazinophthalazine derivatives and diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02LG73",
"display": "C02LG73"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02LG73"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05C",
"display": "Capillary stabilizing agents",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Capillary stabilizing agents"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kapillærstabiliserende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05",
"display": "Vasoprotectives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05C",
"display": "C05C"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05C"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08CA11",
"display": "Manidipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Manidipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Manidipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08CA",
"display": "Dihydropyridine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08CA11",
"display": "C08CA11"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08CA11"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09BB06",
"display": "Enalapril and nitrendipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Enalapril and nitrendipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Enalapril og nitrendipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09BB",
"display": "ACE inhibitors and calcium channel blockers"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09BB06",
"display": "C09BB06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2011-01-01T00:00:00Z",
"display": "2011-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09BB06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AX33",
"display": "Clazosentan",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Clazosentan"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Klazosentan"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04AX",
"display": "Other peripheral vasodilators"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AX33",
"display": "C04AX33"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2024-01-01T00:00:00Z",
"display": "2024-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AX33"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05BB56",
"display": "Glucose, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Glucose, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Glukose, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05BB",
"display": "Sclerosing agents for local injection"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05BB56",
"display": "C05BB56"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05BB56"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AX01",
"display": "Cyclandelate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Cyclandelate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Cyklandelat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04AX",
"display": "Other peripheral vasodilators"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AX01",
"display": "C04AX01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AX01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05AE",
"display": "Muscle relaxants",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Muscle relaxants"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Muskelrelakserende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05A",
"display": "Agents for treatment of hemorrhoids and anal fissures for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05AE",
"display": "C05AE"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2008-01-01T00:00:00Z",
"display": "2008-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05AE"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05CA05",
"display": "Hidrosmin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Hidrosmin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Hidrosmin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05CA",
"display": "Bioflavonoids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05CA05",
"display": "C05CA05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05CA05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AA31",
"display": "Bamethan",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bamethan"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bametan"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04AA",
"display": "2-amino-1-phenylethanol derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AA31",
"display": "C04AA31"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AA31"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07AB12",
"display": "Nebivolol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Nebivolol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nebivolol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07AB",
"display": "Beta blocking agents, selective"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07AB12",
"display": "C07AB12"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07AB12"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02LF",
"display": "Guanidine derivatives and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Guanidine derivatives and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Guanidinderivater og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02L",
"display": "Antihypertensives and diuretics in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02LF",
"display": "C02LF"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02LF"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02CA02",
"display": "Indoramin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Indoramin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Indoramin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02CA",
"display": "Alpha-adrenoreceptor antagonists"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02CA02",
"display": "C02CA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02CA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DX10",
"display": "Dilazep",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Dilazep"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Dilazep"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DX",
"display": "Other vasodilators used in cardiac diseases"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DX10",
"display": "C01DX10"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DX10"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AX02",
"display": "Phenoxybenzamine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Phenoxybenzamine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fenoksybenzamin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04AX",
"display": "Other peripheral vasodilators"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AX02",
"display": "C04AX02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AX02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05AA09",
"display": "Dexamethasone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Dexamethasone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Deksametason"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05AA",
"display": "Corticosteroids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05AA09",
"display": "C05AA09"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05AA09"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08DA01",
"display": "Verapamil",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Verapamil"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Verapamil"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08DA",
"display": "Phenylalkylamine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08DA01",
"display": "C08DA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08DA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DX54",
"display": "Benziodarone, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Benziodarone, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Benziodaron, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DX",
"display": "Other vasodilators used in cardiac diseases"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DX54",
"display": "C01DX54"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DX54"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02LC51",
"display": "Clonidine and diuretics, combinations with other drugs",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Clonidine and diuretics, combinations with other drugs"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Klonidin og diuretika inkl. andre kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02LC",
"display": "Imidazoline receptor agonists in combination with diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02LC51",
"display": "C02LC51"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02LC51"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02L",
"display": "Antihypertensives and diuretics in combination",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Antihypertensives and diuretics in combination"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Antihypertensiva og diuretika i kombinasjon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02",
"display": "Antihypertensives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02L",
"display": "C02L"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02L"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AA02",
"display": "Buphenine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Buphenine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bufenin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04AA",
"display": "2-amino-1-phenylethanol derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AA02",
"display": "C04AA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01BB03",
"display": "Tocainide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Tocainide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tokainid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01BB",
"display": "Antiarrhythmics, class Ib"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01BB03",
"display": "C01BB03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01BB03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05CX",
"display": "Other capillary stabilizing agents",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other capillary stabilizing agents"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre kapillærstabiliserende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05C",
"display": "Capillary stabilizing agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05CX",
"display": "C05CX"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05CX"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BA",
"display": "Combinations of various lipid modifying agents",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Combinations of various lipid modifying agents"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kombinasjoner av ulike lipidmodifiserende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10B",
"display": "Lipid modifying agents, combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BA",
"display": "C10BA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AX26",
"display": "Cetiedil",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Cetiedil"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Cetiedil"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04AX",
"display": "Other peripheral vasodilators"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AX26",
"display": "C04AX26"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AX26"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02CC06",
"display": "Guanazodine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Guanazodine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Guanazodin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02CC",
"display": "Guanidine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02CC06",
"display": "C02CC06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02CC06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09CA06",
"display": "Candesartan",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Candesartan"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kandesartan"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09CA",
"display": "Angiotensin II receptor blockers (ARBs), plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09CA06",
"display": "C09CA06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09CA06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DX15",
"display": "Cloridarol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Cloridarol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kloridarol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DX",
"display": "Other vasodilators used in cardiac diseases"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DX15",
"display": "C01DX15"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DX15"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01B",
"display": "Antiarrhythmics, class I and III",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Antiarrhythmics, class I and III"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Antiarytmika, klasse I og III"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01",
"display": "Cardiac therapy"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01B",
"display": "C01B"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01B"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07BB06",
"display": "Bevantolol and thiazides",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bevantolol and thiazides"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bevantolol og tiazider"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07BB",
"display": "Beta blocking agents, selective, and thiazides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07BB06",
"display": "C07BB06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07BB06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05AD04",
"display": "Cinchocaine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Cinchocaine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Cinkokain"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05AD",
"display": "Local anesthetics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05AD04",
"display": "C05AD04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05AD04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10",
"display": "Lipid modifying agents",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Lipid modifying agents"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Lipidmodifiserende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C",
"display": "Cardiovascular system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10",
"display": "C10"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05AX03",
"display": "Other preparations, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other preparations, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05AX",
"display": "Other agents for treatment of hemorrhoids and anal fissures for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05AX03",
"display": "C05AX03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05AX03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02AA02",
"display": "Reserpine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Reserpine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Reserpin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02AA",
"display": "Rauwolfia alkaloids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02AA02",
"display": "C02AA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02AA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AA04",
"display": "Fluvastatin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Fluvastatin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fluvastatin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AA",
"display": "HMG CoA reductase inhibitors"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AA04",
"display": "C10AA04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AA04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07FX02",
"display": "Sotalol and acetylsalicylic acid",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Sotalol and acetylsalicylic acid"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Sotalol og acetylsalisylsyre"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07FX",
"display": "Beta blocking agents, other combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07FX02",
"display": "C07FX02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07FX02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02LA",
"display": "Rauwolfia alkaloids and diuretics in combination",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Rauwolfia alkaloids and diuretics in combination"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Rauwolfiaalkaloider og diuretika i kombinasjon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02L",
"display": "Antihypertensives and diuretics in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02LA",
"display": "C02LA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02LA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AB08",
"display": "Ciprofibrate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ciprofibrate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ciprofibrat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AB",
"display": "Fibrates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AB08",
"display": "C10AB08"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AB08"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AX03",
"display": "Tiadenol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Tiadenol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tiadenol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AX",
"display": "Other lipid modifying agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AX03",
"display": "C10AX03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AX03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07BB04",
"display": "Acebutolol and thiazides",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Acebutolol and thiazides"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Acebutolol og tiazider"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07BB",
"display": "Beta blocking agents, selective, and thiazides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07BB04",
"display": "C07BB04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07BB04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CA28",
"display": "Centhaquine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Centhaquine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Centakvin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CA",
"display": "Adrenergic and dopaminergic agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CA28",
"display": "C01CA28"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2023-12-05T00:00:00Z",
"display": "2023-12-05T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CA28"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03D",
"display": "Aldosterone antagonists and other potassium-sparing agents",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Aldosterone antagonists and other potassium-sparing agents"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Aldosteronantagonister og andre kaliumsparende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03",
"display": "Diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03D",
"display": "C03D"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03D"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05BA53",
"display": "Heparin, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Heparin, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Heparin, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05BA",
"display": "Heparins or heparinoids for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05BA53",
"display": "C05BA53"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05BA53"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01BA08",
"display": "Prajmaline",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Prajmaline"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Prajmalin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01BA",
"display": "Antiarrhythmics, class Ia"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01BA08",
"display": "C01BA08"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01BA08"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02LL01",
"display": "Pargyline and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Pargyline and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Pargylin og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02LL",
"display": "MAO inhibitors and diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02LL01",
"display": "C02LL01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02LL01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CA23",
"display": "Theodrenaline",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Theodrenaline"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Teodrenalin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CA",
"display": "Adrenergic and dopaminergic agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CA23",
"display": "C01CA23"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CA23"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BA10",
"display": "Bempedoic acid and ezetimibe",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bempedoic acid and ezetimibe"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bempedoinsyre og ezetimib"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10BA",
"display": "Combinations of various lipid modifying agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BA10",
"display": "C10BA10"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2020-10-15T00:00:00Z",
"display": "2020-10-15T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BA10"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BX16",
"display": "Rosuvastatin and fimasartan",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Rosuvastatin and fimasartan"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Rosuvastatin og fimasartan"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10BX",
"display": "Lipid modifying agents in combination with other drugs"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BX16",
"display": "C10BX16"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2019-04-10T00:00:00Z",
"display": "2019-04-10T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BX16"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02DG",
"display": "Guanidine derivatives",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Guanidine derivatives"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Guanidinderivater"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02D",
"display": "Arteriolar smooth muscle, agents acting on"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02DG",
"display": "C02DG"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02DG"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07BG01",
"display": "Labetalol and thiazides",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Labetalol and thiazides"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Labetalol og tiazider"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07BG",
"display": "Alpha and beta blocking agents and thiazides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07BG01",
"display": "C07BG01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07BG01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AX18",
"display": "Volanesorsen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Volanesorsen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Volanesorsen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AX",
"display": "Other lipid modifying agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AX18",
"display": "C10AX18"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2021-03-04T00:00:00Z",
"display": "2021-03-04T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AX18"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03BA08",
"display": "Metolazone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Metolazone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Metolazon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03BA",
"display": "Sulfonamides, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03BA08",
"display": "C03BA08"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03BA08"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02CC02",
"display": "Guanethidine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Guanethidine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Guanetidin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02CC",
"display": "Guanidine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02CC02",
"display": "C02CC02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02CC02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01BD",
"display": "Antiarrhythmics, class III",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Antiarrhythmics, class III"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Antiarytmika, klasse III"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01B",
"display": "Antiarrhythmics, class I and III"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01BD",
"display": "C01BD"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01BD"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02DA",
"display": "Thiazide derivatives",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Thiazide derivatives"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tiazidderivater"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02D",
"display": "Arteriolar smooth muscle, agents acting on"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02DA",
"display": "C02DA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02DA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03AH02",
"display": "Hydroflumethiazide, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Hydroflumethiazide, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Hydroflumetiazid, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03AH",
"display": "Thiazides, combinations with psycholeptics and/or analgesics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03AH02",
"display": "C03AH02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03AH02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CA04",
"display": "Dopamine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Dopamine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Dopamin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CA",
"display": "Adrenergic and dopaminergic agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CA04",
"display": "C01CA04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CA04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05AX04",
"display": "Zinc preparations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Zinc preparations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Sinkmidler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05AX",
"display": "Other agents for treatment of hemorrhoids and anal fissures for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05AX04",
"display": "C05AX04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05AX04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DA13",
"display": "Eritrityl tetranitrate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Eritrityl tetranitrate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Erytritoltetranitrat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DA",
"display": "Organic nitrates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DA13",
"display": "C01DA13"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DA13"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01BC08",
"display": "Encainide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Encainide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Enkainid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01BC",
"display": "Antiarrhythmics, class Ic"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01BC08",
"display": "C01BC08"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01BC08"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02AA06",
"display": "Methoserpidine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Methoserpidine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Metoserpidin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02AA",
"display": "Rauwolfia alkaloids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02AA06",
"display": "C02AA06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02AA06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03AA07",
"display": "Cyclopenthiazide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Cyclopenthiazide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Cyklopentiazid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03AA",
"display": "Thiazides, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03AA07",
"display": "C03AA07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03AA07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04",
"display": "Peripheral vasodilators",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Peripheral vasodilators"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Perifere kardilaterende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C",
"display": "Cardiovascular system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04",
"display": "C04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02AB02",
"display": "Methyldopa (racemic)",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Methyldopa (racemic)"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Metyldopa (rasemisk)"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02AB",
"display": "Methyldopa"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02AB02",
"display": "C02AB02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02AB02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03AB04",
"display": "Chlorothiazide and potassium",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Chlorothiazide and potassium"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Klortiazid og kalium"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03AB",
"display": "Thiazides and potassium in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03AB04",
"display": "C03AB04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03AB04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07AA01",
"display": "Alprenolol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Alprenolol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Alprenolol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07AA",
"display": "Beta blocking agents, non-selective"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07AA01",
"display": "C07AA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07AA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AX05",
"display": "Meglutol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Meglutol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Meglutol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AX",
"display": "Other lipid modifying agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AX05",
"display": "C10AX05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AX05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CX06",
"display": "Angiotensinamide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Angiotensinamide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Angiotensinamid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CX",
"display": "Other cardiac stimulants"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CX06",
"display": "C01CX06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CX06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05AA",
"display": "Corticosteroids",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Corticosteroids"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kortikosteroider"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05A",
"display": "Agents for treatment of hemorrhoids and anal fissures for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05AA",
"display": "C05AA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05AA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AC03",
"display": "Colextran",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Colextran"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kolekstran"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AC",
"display": "Bile acid sequestrants"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AC03",
"display": "C10AC03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AC03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02KA01",
"display": "Veratrum",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Veratrum"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Veratrum"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02KA",
"display": "Alkaloids, excl. rauwolfia"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02KA01",
"display": "C02KA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02KA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BX07",
"display": "Rosuvastatin, amlodipine and lisinopril",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Rosuvastatin, amlodipine and lisinopril"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Rosuvastatin, amlodipin og lisinopril"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10BX",
"display": "Lipid modifying agents in combination with other drugs"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BX07",
"display": "C10BX07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2014-02-20T00:00:00Z",
"display": "2014-02-20T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BX07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09DB02",
"display": "Olmesartan medoxomil and amlodipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Olmesartan medoxomil and amlodipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Olmesartanmedoksomil og amlodipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09DB",
"display": "Angiotensin II receptor blockers (ARBs) and calcium channel blockers"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09DB02",
"display": "C09DB02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2009-03-13T00:00:00Z",
"display": "2009-03-13T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09DB02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07BA",
"display": "Beta blocking agents, non-selective, and thiazides",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Beta blocking agents, non-selective, and thiazides"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Betablokkere, ikke-selektive, og tiazider"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07B",
"display": "Beta blocking agents and thiazider"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07BA",
"display": "C07BA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07BA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03BK",
"display": "Sulfonamides, combinations with other drugs",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Sulfonamides, combinations with other drugs"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Sulfonamider, kombinasjoner med andre midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03B",
"display": "Low-ceiling diuretics, excl. thiazides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03BK",
"display": "C03BK"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03BK"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02KX04",
"display": "Macitentan",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Macitentan"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Macitentan"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02KX",
"display": "Antihypertensives for pulmonary arterial hypertension"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02KX04",
"display": "C02KX04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2013-11-01T00:00:00Z",
"display": "2013-11-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02KX04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DX13",
"display": "Efloxate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Efloxate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Efloksat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DX",
"display": "Other vasodilators used in cardiac diseases"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DX13",
"display": "C01DX13"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DX13"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01EB04",
"display": "Crataegus glycosides",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Crataegus glycosides"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Krategusglykosider"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01EB",
"display": "Other cardiac preparations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01EB04",
"display": "C01EB04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01EB04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02KX01",
"display": "Bosentan",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bosentan"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bosentan"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02KX",
"display": "Antihypertensives for pulmonary arterial hypertension"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02KX01",
"display": "C02KX01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2003-07-21T00:00:00Z",
"display": "2003-07-21T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02KX01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09BB13",
"display": "Benazepril and amlodipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Benazepril and amlodipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Benazepril og amlodipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09BB",
"display": "ACE inhibitors and calcium channel blockers"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09BB13",
"display": "C09BB13"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2022-05-05T00:00:00Z",
"display": "2022-05-05T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09BB13"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01EB07",
"display": "Fructose 1,6-diphosphate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Fructose 1,6-diphosphate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fruktose 1,6-difosfat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01EB",
"display": "Other cardiac preparations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01EB07",
"display": "C01EB07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01EB07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CA02",
"display": "Isoprenaline",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Isoprenaline"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Isoprenalin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CA",
"display": "Adrenergic and dopaminergic agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CA02",
"display": "C01CA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02LE",
"display": "Alpha-adrenoreceptor antagonists and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Alpha-adrenoreceptor antagonists and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Alfablokkere og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02L",
"display": "Antihypertensives and diuretics in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02LE",
"display": "C02LE"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02LE"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07AB07",
"display": "Bisoprolol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bisoprolol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bisoprolol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07AB",
"display": "Beta blocking agents, selective"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07AB07",
"display": "C07AB07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07AB07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CE",
"display": "Phosphodiesterase inhibitors",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Phosphodiesterase inhibitors"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fosfodiesterasehemmere"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01C",
"display": "Cardiac stimulants excl. cardiac glycosides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CE",
"display": "C01CE"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CE"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01BA13",
"display": "Hydroquinidine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Hydroquinidine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Hydrokinidin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01BA",
"display": "Antiarrhythmics, class Ia"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01BA13",
"display": "C01BA13"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2016-12-20T00:00:00Z",
"display": "2016-12-20T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01BA13"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DA70",
"display": "Organic nitrates in combination with psycholeptics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Organic nitrates in combination with psycholeptics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nitrater i kombinasjon med psykoleptika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DA",
"display": "Organic nitrates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DA70",
"display": "C01DA70"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DA70"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09BB",
"display": "ACE inhibitors and calcium channel blockers",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "ACE inhibitors and calcium channel blockers"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "ACE-hemmere og kalsiumantagonister"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09B",
"display": "ACE inhibitors, combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09BB",
"display": "C09BB"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09BB"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03AB",
"display": "Thiazides and potassium in combination",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Thiazides and potassium in combination"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tiazider og kalium i kombinasjon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03A",
"display": "Low-ceiling diuretics, thiazides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03AB",
"display": "C03AB"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03AB"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07EA",
"display": "Beta blocking agents, non-selective, and vasodilators",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Beta blocking agents, non-selective, and vasodilators"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Betablokkere, ikke-selektive, og vasodilaterende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07E",
"display": "Beta blocking agents and vasodilators"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07EA",
"display": "C07EA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07EA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02AC06",
"display": "Rilmenidine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Rilmenidine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Rilmenidin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02AC",
"display": "Imidazoline receptor agonists"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02AC06",
"display": "C02AC06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02AC06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09BX03",
"display": "Ramipril, amlodipine and hydrochlorothiazide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ramipril, amlodipine and hydrochlorothiazide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ramipril, amlodipin og hydroklortiazid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09BX",
"display": "ACE inhibitors, other combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09BX03",
"display": "C09BX03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2017-01-10T00:00:00Z",
"display": "2017-01-10T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09BX03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CA15",
"display": "Gepefrine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Gepefrine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Gepefrin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CA",
"display": "Adrenergic and dopaminergic agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CA15",
"display": "C01CA15"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CA15"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01BG01",
"display": "Moracizine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Moracizine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Moracizin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01BG",
"display": "Other antiarrhythmics, class I and III"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01BG01",
"display": "C01BG01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01BG01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AX23",
"display": "Butalamine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Butalamine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Butalamin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04AX",
"display": "Other peripheral vasodilators"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AX23",
"display": "C04AX23"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AX23"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03EA06",
"display": "Chlortalidone and potassium-sparing agents",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Chlortalidone and potassium-sparing agents"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Klortalidon og kaliumsparende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03EA",
"display": "Low-ceiling diuretics and potassium-sparing agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03EA06",
"display": "C03EA06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03EA06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09X",
"display": "Other agents acting on the renin-angiotensin system",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other agents acting on the renin-angiotensin system"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre midler med virkning på renin-angiotensin systemet"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09",
"display": "Agents acting on the renin-angiotensin system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09X",
"display": "C09X"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09X"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AD04",
"display": "Etofylline nicotinate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Etofylline nicotinate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Etofyllinnikotinat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04AD",
"display": "Purine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AD04",
"display": "C04AD04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AD04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02KB01",
"display": "Metirosine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Metirosine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Metirosin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02KB",
"display": "Tyrosine hydroxylase inhibitors"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02KB01",
"display": "C02KB01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02KB01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09C",
"display": "Angiotensin II receptor blockers (ARBs), plain",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Angiotensin II receptor blockers (ARBs), plain"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Angiotensin II reseptorblokkere (ARBs), usammensatte"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09",
"display": "Agents acting on the renin-angiotensin system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09C",
"display": "C09C"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09C"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08DA51",
"display": "Verapamil, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Verapamil, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Verapamil, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08DA",
"display": "Phenylalkylamine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08DA51",
"display": "C08DA51"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08DA51"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02D",
"display": "Arteriolar smooth muscle, agents acting on",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Arteriolar smooth muscle, agents acting on"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Antihypertensiva med virkning på arteriolær glatt muskel"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02",
"display": "Antihypertensives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02D",
"display": "C02D"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02D"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09A",
"display": "ACE inhibitors, plain",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "ACE inhibitors, plain"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "ACE-hemmere, usammensatte"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09",
"display": "Agents acting on the renin-angiotensin system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09A",
"display": "C09A"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09A"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01AA08",
"display": "Metildigoxin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Metildigoxin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Metyldigoksin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01AA",
"display": "Digitalis glycosides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01AA08",
"display": "C01AA08"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01AA08"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AB",
"display": "Imidazoline derivatives",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Imidazoline derivatives"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Imidazolinderivater"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04A",
"display": "Peripheral vasodilators"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AB",
"display": "C04AB"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AB"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09BA08",
"display": "Cilazapril and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Cilazapril and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Cilazapril og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09BA",
"display": "ACE inhibitors and diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09BA08",
"display": "C09BA08"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09BA08"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02BB01",
"display": "Mecamylamine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Mecamylamine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Mekamylamin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02BB",
"display": "Secondary and tertiary amines"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02BB01",
"display": "C02BB01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02BB01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05AD05",
"display": "Procaine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Procaine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Prokain"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05AD",
"display": "Local anesthetics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05AD05",
"display": "C05AD05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05AD05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03EA",
"display": "Low-ceiling diuretics and potassium-sparing agents",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Low-ceiling diuretics and potassium-sparing agents"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Low-ceiling diuretika og kaliumsparende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03E",
"display": "Diuretics and potassium-sparing agents in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03EA",
"display": "C03EA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03EA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07CB53",
"display": "Atenolol and other diuretics, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Atenolol and other diuretics, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Atenolol og andre diuretika, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07CB",
"display": "Beta blocking agents, selective, and other diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07CB53",
"display": "C07CB53"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07CB53"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02AB",
"display": "Methyldopa",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Methyldopa"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Metyldopa"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02A",
"display": "Antiadrenergic agents, centrally acting"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02AB",
"display": "C02AB"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02AB"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03CD",
"display": "Pyrazolone derivatives",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Pyrazolone derivatives"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Pyrazolonderivater"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03C",
"display": "High-ceiling diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03CD",
"display": "C03CD"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03CD"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05AE01",
"display": "Glyceryl trinitrate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Glyceryl trinitrate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Glyseryltrinitrat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05AE",
"display": "Muscle relaxants"
}
},
{
"code": "previousVersion",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/f5a60497-f1c5-4163-ad34-a3c614d2f6b4",
"code": "D03AX07",
"display": "Glyceryl trinitrate"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05AE01",
"display": "C05AE01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2008-01-01T00:00:00Z",
"display": "2008-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05AE01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08",
"display": "Calcium channel blockers",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Calcium channel blockers"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kalsiumantagonister"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C",
"display": "Cardiovascular system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08",
"display": "C08"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02LG03",
"display": "Picodralazine and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Picodralazine and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Pikodralazin og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02LG",
"display": "Hydrazinophthalazine derivatives and diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02LG03",
"display": "C02LG03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02LG03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01AA09",
"display": "Gitoformate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Gitoformate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Gitoformat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01AA",
"display": "Digitalis glycosides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01AA09",
"display": "C01AA09"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01AA09"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07BB07",
"display": "Bisoprolol and thiazides",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bisoprolol and thiazides"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bisoprolol og tiazider"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07BB",
"display": "Beta blocking agents, selective, and thiazides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07BB07",
"display": "C07BB07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07BB07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10A",
"display": "Lipid modifying agents, plain",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Lipid modifying agents, plain"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Lipidmodifiserende midler, usammensatte"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10",
"display": "Lipid modifying agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10A",
"display": "C10A"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10A"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08CA51",
"display": "Amlodipine and celecoxib",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Amlodipine and celecoxib"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Amlodipin og celekoksib"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08CA",
"display": "Dihydropyridine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08CA51",
"display": "C08CA51"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2019-04-08T00:00:00Z",
"display": "2019-04-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08CA51"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09XA",
"display": "Renin-inhibitors",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Renin-inhibitors"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Reninhemmere"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09X",
"display": "Other agents acting on the renin-angiotensin system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09XA",
"display": "C09XA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09XA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08DB",
"display": "Benzothiazepine derivatives",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Benzothiazepine derivatives"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Benzotiazepinderivater"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08D",
"display": "Selective calcium channel blockers with direct cardiac effects"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08DB",
"display": "C08DB"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08DB"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AD52",
"display": "Nicotinic acid, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Nicotinic acid, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nikotinsyre, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AD",
"display": "Nicotinic acid and derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AD52",
"display": "C10AD52"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2009-01-01T00:00:00Z",
"display": "2009-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AD52"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09AA13",
"display": "Moexipril",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Moexipril"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Moeksipril"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09AA",
"display": "ACE inhibitors, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09AA13",
"display": "C09AA13"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09AA13"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01BC09",
"display": "Ethacizine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ethacizine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Etacizin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01BC",
"display": "Antiarrhythmics, class Ic"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01BC09",
"display": "C01BC09"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2013-12-10T00:00:00Z",
"display": "2013-12-10T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01BC09"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02LA51",
"display": "Reserpine and diuretics, combinations with other drugs",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Reserpine and diuretics, combinations with other drugs"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Reserpin og diuretika, kombinasjoner med andre midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02LA",
"display": "Rauwolfia alkaloids and diuretics in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02LA51",
"display": "C02LA51"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02LA51"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07AA23",
"display": "Penbutolol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Penbutolol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Penbutolol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07AA",
"display": "Beta blocking agents, non-selective"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07AA23",
"display": "C07AA23"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07AA23"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DX04",
"display": "Benziodarone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Benziodarone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Benziodaron"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DX",
"display": "Other vasodilators used in cardiac diseases"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DX04",
"display": "C01DX04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DX04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DA55",
"display": "Pentaerithrityl tetranitrate, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Pentaerithrityl tetranitrate, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Pentaeritrityltetranitrat, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DA",
"display": "Organic nitrates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DA55",
"display": "C01DA55"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DA55"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02KX02",
"display": "Ambrisentan",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ambrisentan"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ambrisentan"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02KX",
"display": "Antihypertensives for pulmonary arterial hypertension"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02KX02",
"display": "C02KX02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2007-01-01T00:00:00Z",
"display": "2007-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02KX02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02AA01",
"display": "Rescinnamine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Rescinnamine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Reskinnamin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02AA",
"display": "Rauwolfia alkaloids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02AA01",
"display": "C02AA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02AA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09BA04",
"display": "Perindopril and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Perindopril and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Perindopril og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09BA",
"display": "ACE inhibitors and diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09BA04",
"display": "C09BA04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09BA04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AD02",
"display": "Nicotinic acid",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Nicotinic acid"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nikotinsyre"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AD",
"display": "Nicotinic acid and derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AD02",
"display": "C10AD02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AD02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CA19",
"display": "Fenoldopam",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Fenoldopam"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fenoldopam"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CA",
"display": "Adrenergic and dopaminergic agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CA19",
"display": "C01CA19"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CA19"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03BA07",
"display": "Clofenamide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Clofenamide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Klofenamid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03BA",
"display": "Sulfonamides, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03BA07",
"display": "C03BA07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03BA07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07CG01",
"display": "Labetalol and other diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Labetalol and other diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Labetalol og andre diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07CG",
"display": "Alpha and beta blocking agents and other diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07CG01",
"display": "C07CG01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07CG01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07EB",
"display": "Beta blocking agents, selective, and vasodilators",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Beta blocking agents, selective, and vasodilators"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Betablokkere, selektive, og vasodilaterende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07E",
"display": "Beta blocking agents and vasodilators"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07EB",
"display": "C07EB"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07EB"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DX01",
"display": "Itramin tosilate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Itramin tosilate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Itramintosilat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DX",
"display": "Other vasodilators used in cardiac diseases"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DX01",
"display": "C01DX01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DX01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AC02",
"display": "Colestipol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Colestipol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kolestipol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AC",
"display": "Bile acid sequestrants"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AC02",
"display": "C10AC02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AC02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CA12",
"display": "Dimetofrine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Dimetofrine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Dimetofrin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CA",
"display": "Adrenergic and dopaminergic agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CA12",
"display": "C01CA12"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CA12"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01AC03",
"display": "Cymarin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Cymarin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Cymarin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01AC",
"display": "Strophantus glycosides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01AC03",
"display": "C01AC03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01AC03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BA09",
"display": "Rosuvastatin and fenofibrate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Rosuvastatin and fenofibrate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Rosuvastatin og fenofibrat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10BA",
"display": "Combinations of various lipid modifying agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BA09",
"display": "C10BA09"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2019-12-15T00:00:00Z",
"display": "2019-12-15T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BA09"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01BA01",
"display": "Quinidine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Quinidine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kinidin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01BA",
"display": "Antiarrhythmics, class Ia"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01BA01",
"display": "C01BA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01BA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05AA11",
"display": "Fluocinonide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Fluocinonide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fluocinonid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05AA",
"display": "Corticosteroids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05AA11",
"display": "C05AA11"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05AA11"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09DA09",
"display": "Azilsartan medoxomil and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Azilsartan medoxomil and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Azilsartanmedoksomil og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09DA",
"display": "Angiotensin II receptor blockers (ARBs) and diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09DA09",
"display": "C09DA09"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2014-02-20T00:00:00Z",
"display": "2014-02-20T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09DA09"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CA16",
"display": "Ibopamine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ibopamine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ibopamin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CA",
"display": "Adrenergic and dopaminergic agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CA16",
"display": "C01CA16"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CA16"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09AA02",
"display": "Enalapril",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Enalapril"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Enalapril"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09AA",
"display": "ACE inhibitors, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09AA02",
"display": "C09AA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09AA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BX10",
"display": "Rosuvastatin and valsartan",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Rosuvastatin and valsartan"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Rosuvastatin og valsartan"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10BX",
"display": "Lipid modifying agents in combination with other drugs"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BX10",
"display": "C10BX10"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2015-01-22T00:00:00Z",
"display": "2015-01-22T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BX10"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DX52",
"display": "Prenylamine, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Prenylamine, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Prenylamin, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DX",
"display": "Other vasodilators used in cardiac diseases"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DX52",
"display": "C01DX52"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DX52"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03DA04",
"display": "Eplerenone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Eplerenone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Eplerenon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03DA",
"display": "Aldosterone antagonists"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03DA04",
"display": "C03DA04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2004-08-27T00:00:00Z",
"display": "2004-08-27T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03DA04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02LB",
"display": "Methyldopa and diuretics in combination",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Methyldopa and diuretics in combination"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Metyldopa og diuretika i kombinasjon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02L",
"display": "Antihypertensives and diuretics in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02LB",
"display": "C02LB"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02LB"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02LC",
"display": "Imidazoline receptor agonists in combination with diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Imidazoline receptor agonists in combination with diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Imidazolinreseptoragonister kombinasjoner med diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02L",
"display": "Antihypertensives and diuretics in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02LC",
"display": "C02LC"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02LC"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03AB08",
"display": "Methyclothiazide and potassium",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Methyclothiazide and potassium"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Metyklotiazid og kalium"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03AB",
"display": "Thiazides and potassium in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03AB08",
"display": "C03AB08"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03AB08"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AB02",
"display": "Tolazoline",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Tolazoline"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tolazolin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04AB",
"display": "Imidazoline derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AB02",
"display": "C04AB02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AB02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03AB03",
"display": "Hydrochlorothiazide and potassium",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Hydrochlorothiazide and potassium"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Hydroklortiazid og kalium"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03AB",
"display": "Thiazides and potassium in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03AB03",
"display": "C03AB03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03AB03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BA05",
"display": "Atorvastatin and ezetimibe",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Atorvastatin and ezetimibe"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Atorvastatin og ezetimib"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10BA",
"display": "Combinations of various lipid modifying agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BA05",
"display": "C10BA05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2013-01-28T00:00:00Z",
"display": "2013-01-28T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BA05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01EX",
"display": "Other cardiac combination products",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other cardiac combination products"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre kombinasjoner for hjerteterapi"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01E",
"display": "Other cardiac preparations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01EX",
"display": "C01EX"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01EX"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02LL",
"display": "MAO inhibitors and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "MAO inhibitors and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "MAO-hemmere og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02L",
"display": "Antihypertensives and diuretics in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02LL",
"display": "C02LL"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02LL"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08CA13",
"display": "Lercanidipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Lercanidipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Lerkanidipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08CA",
"display": "Dihydropyridine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08CA13",
"display": "C08CA13"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08CA13"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AE04",
"display": "Dihydroergocristine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Dihydroergocristine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Dihydroergokristin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04AE",
"display": "Ergot alkaloids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AE04",
"display": "C04AE04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AE04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03BC01",
"display": "Mersalyl",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Mersalyl"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Mersalyl"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03BC",
"display": "Mercurial diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03BC01",
"display": "C03BC01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03BC01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07AA05",
"display": "Propranolol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Propranolol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Propranolol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07AA",
"display": "Beta blocking agents, non-selective"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07AA05",
"display": "C07AA05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07AA05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05BA03",
"display": "Heparin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Heparin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Heparin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05BA",
"display": "Heparins or heparinoids for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05BA03",
"display": "C05BA03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05BA03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AB02",
"display": "Bezafibrate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bezafibrate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bezafibrat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AB",
"display": "Fibrates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AB02",
"display": "C10AB02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AB02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AB04",
"display": "Gemfibrozil",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Gemfibrozil"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Gemfibrozil"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AB",
"display": "Fibrates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AB04",
"display": "C10AB04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AB04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03AA09",
"display": "Cyclothiazide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Cyclothiazide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Cyklotiazid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03AA",
"display": "Thiazides, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03AA09",
"display": "C03AA09"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03AA09"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01BA03",
"display": "Disopyramide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Disopyramide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Disopyramid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01BA",
"display": "Antiarrhythmics, class Ia"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01BA03",
"display": "C01BA03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01BA03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03AA08",
"display": "Methyclothiazide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Methyclothiazide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Metyklotiazid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03AA",
"display": "Thiazides, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03AA08",
"display": "C03AA08"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03AA08"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05BA",
"display": "Heparins or heparinoids for topical use",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Heparins or heparinoids for topical use"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Hepariner eller heparinoider til topikal bruk"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05B",
"display": "Antivaricose therapy"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05BA",
"display": "C05BA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05BA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03AX01",
"display": "Hydrochlorothiazide, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Hydrochlorothiazide, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Hydroklortiazid, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03AX",
"display": "Thiazides, combinations with other drugs"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03AX01",
"display": "C03AX01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03AX01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05AD06",
"display": "Oxetacaine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Oxetacaine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Oksetakain"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05AD",
"display": "Local anesthetics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05AD06",
"display": "C05AD06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05AD06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01EB21",
"display": "Regadenoson",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Regadenoson"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Regadenoson"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01EB",
"display": "Other cardiac preparations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01EB21",
"display": "C01EB21"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2010-01-01T00:00:00Z",
"display": "2010-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01EB21"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AB12",
"display": "Pemafibrate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Pemafibrate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Pemafibrat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AB",
"display": "Fibrates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AB12",
"display": "C10AB12"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2023-11-15T00:00:00Z",
"display": "2023-11-15T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AB12"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DX21",
"display": "Serelaxin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Serelaxin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Serelaksin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DX",
"display": "Other vasodilators used in cardiac diseases"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DX21",
"display": "C01DX21"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2013-12-10T00:00:00Z",
"display": "2013-12-10T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DX21"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03CA04",
"display": "Torasemide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Torasemide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Torasemid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03CA",
"display": "Sulfonamides, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03CA04",
"display": "C03CA04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03CA04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02CC",
"display": "Guanidine derivatives",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Guanidine derivatives"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Guanidinderivater"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02C",
"display": "Antiadrenergic agents, peripherally acting"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02CC",
"display": "C02CC"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02CC"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02AC02",
"display": "Guanfacine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Guanfacine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Guanfacin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02AC",
"display": "Imidazoline receptor agonists"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02AC02",
"display": "C02AC02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02AC02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02LX01",
"display": "Pinacidil and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Pinacidil and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Pinacidil og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02LX",
"display": "Other antihypertensives and diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02LX01",
"display": "C02LX01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02LX01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09AA15",
"display": "Zofenopril",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Zofenopril"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Zofenopril"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09AA",
"display": "ACE inhibitors, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09AA15",
"display": "C09AA15"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09AA15"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08CA06",
"display": "Nimodipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Nimodipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nimodipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08CA",
"display": "Dihydropyridine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08CA06",
"display": "C08CA06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08CA06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07FA",
"display": "Beta blocking agents, non-selective, and other antihypertensives",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Beta blocking agents, non-selective, and other antihypertensives"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Betablokkere, ikke selektive, og andre antihypertensiva"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07F",
"display": "Beta blocking agents, other combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07FA",
"display": "C07FA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "toDate",
"valueCoding": {
"code": "2017-06-14T00:00:00Z",
"display": "2017-06-14T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07FA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Slettet",
"display": "Slettet"
}
}
]
},
{
"code": "C02DB03",
"display": "Endralazine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Endralazine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Endralazin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02DB",
"display": "Hydrazinophthalazine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02DB03",
"display": "C02DB03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02DB03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DX07",
"display": "Etafenone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Etafenone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Etafenon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DX",
"display": "Other vasodilators used in cardiac diseases"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DX07",
"display": "C01DX07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DX07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03CD01",
"display": "Muzolimine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Muzolimine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Muzolimin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03CD",
"display": "Pyrazolone derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03CD01",
"display": "C03CD01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03CD01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09BX01",
"display": "Perindopril, amlodipine and indapamide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Perindopril, amlodipine and indapamide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Perindopril, amlodipin og indapamid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09BX",
"display": "ACE inhibitors, other combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09BX01",
"display": "C09BX01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2013-12-10T00:00:00Z",
"display": "2013-12-10T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09BX01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08CA10",
"display": "Nilvadipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Nilvadipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nilvadipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08CA",
"display": "Dihydropyridine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08CA10",
"display": "C08CA10"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08CA10"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03DB01",
"display": "Amiloride",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Amiloride"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Amilorid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03DB",
"display": "Other potassium-sparing agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03DB01",
"display": "C03DB01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03DB01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02LA03",
"display": "Deserpidine and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Deserpidine and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Deserpidin og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02LA",
"display": "Rauwolfia alkaloids and diuretics in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02LA03",
"display": "C02LA03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02LA03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01BD04",
"display": "Dofetilide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Dofetilide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Dofetilid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01BD",
"display": "Antiarrhythmics, class III"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01BD04",
"display": "C01BD04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01BD04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07AA19",
"display": "Bupranolol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bupranolol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bupranolol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07AA",
"display": "Beta blocking agents, non-selective"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07AA19",
"display": "C07AA19"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07AA19"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09AA01",
"display": "Captopril",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Captopril"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kaptopril"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09AA",
"display": "ACE inhibitors, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09AA01",
"display": "C09AA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09AA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AX08",
"display": "Policosanol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Policosanol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Polikosanol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AX",
"display": "Other lipid modifying agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AX08",
"display": "C10AX08"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AX08"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08EA",
"display": "Phenylalkylamine derivatives",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Phenylalkylamine derivatives"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fenylalkylaminderivater"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08E",
"display": "Non-selective calcium channel blockers"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08EA",
"display": "C08EA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08EA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DX08",
"display": "Heptaminol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Heptaminol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Heptaminol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DX",
"display": "Other vasodilators used in cardiac diseases"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DX08",
"display": "C01DX08"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DX08"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AX30",
"display": "Azapetine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Azapetine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Azapetin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04AX",
"display": "Other peripheral vasodilators"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AX30",
"display": "C04AX30"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AX30"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09DB06",
"display": "Losartan and amlodipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Losartan and amlodipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Losartan og amlodipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09DB",
"display": "Angiotensin II receptor blockers (ARBs) and calcium channel blockers"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09DB06",
"display": "C09DB06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2012-01-01T00:00:00Z",
"display": "2012-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09DB06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02KC",
"display": "MAO inhibitors",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "MAO inhibitors"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "MAO-hemmere"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02K",
"display": "Other antihypertensives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02KC",
"display": "C02KC"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02KC"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01EB",
"display": "Other cardiac preparations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other cardiac preparations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre midler for hjerteterapi"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01E",
"display": "Other cardiac preparations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01EB",
"display": "C01EB"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01EB"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01EB12",
"display": "Tedisamil",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Tedisamil"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tedisamil"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01EB",
"display": "Other cardiac preparations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01EB12",
"display": "C01EB12"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "toDate",
"valueCoding": {
"code": "2009-01-01T00:00:00Z",
"display": "2009-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01EB12"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Slettet",
"display": "Slettet"
}
}
]
},
{
"code": "C01AA",
"display": "Digitalis glycosides",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Digitalis glycosides"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Digitalisglykosider"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01A",
"display": "Cardiac glycosides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01AA",
"display": "C01AA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01AA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03X",
"display": "Other diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03",
"display": "Diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03X",
"display": "C03X"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2009-03-20T00:00:00Z",
"display": "2009-03-20T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03X"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01BC",
"display": "Antiarrhythmics, class Ic",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Antiarrhythmics, class Ic"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Antiarytmika, klasse Ic"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01B",
"display": "Antiarrhythmics, class I and III"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01BC",
"display": "C01BC"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01BC"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AX32",
"display": "Fasudil",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Fasudil"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fasudil"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04AX",
"display": "Other peripheral vasodilators"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AX32",
"display": "C04AX32"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AX32"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01BB01",
"display": "Lidocaine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Lidocaine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Lidokain"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01BB",
"display": "Antiarrhythmics, class Ib"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01BB01",
"display": "C01BB01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01BB01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02DD01",
"display": "Nitroprusside",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Nitroprusside"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nitroprussid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02DD",
"display": "Nitroferricyanide derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02DD01",
"display": "C02DD01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02DD01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05AD07",
"display": "Pramocaine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Pramocaine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Pramokain"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05AD",
"display": "Local anesthetics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05AD07",
"display": "C05AD07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05AD07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03CA02",
"display": "Bumetanide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bumetanide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bumetanid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03CA",
"display": "Sulfonamides, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03CA02",
"display": "C03CA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03CA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05AA01",
"display": "Hydrocortisone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Hydrocortisone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Hydrokortison"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05AA",
"display": "Corticosteroids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05AA01",
"display": "C05AA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05AA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02KB",
"display": "Tyrosine hydroxylase inhibitors",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Tyrosine hydroxylase inhibitors"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tyrosinhydroksylasehemmere"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02K",
"display": "Other antihypertensives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02KB",
"display": "C02KB"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02KB"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02KN",
"display": "Other antihypertensives",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other antihypertensives"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre antihypertensiva"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02K",
"display": "Other antihypertensives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02KN",
"display": "C02KN"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2023-11-14T00:00:00Z",
"display": "2023-11-14T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02KN"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05BB04",
"display": "Sodium tetradecyl sulfate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Sodium tetradecyl sulfate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Natriumtetradekylsulfat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05BB",
"display": "Sclerosing agents for local injection"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05BB04",
"display": "C05BB04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05BB04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CE03",
"display": "Enoximone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Enoximone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Enoksimon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CE",
"display": "Phosphodiesterase inhibitors"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CE03",
"display": "C01CE03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CE03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09DA08",
"display": "Olmesartan medoxomil and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Olmesartan medoxomil and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Olmesartanmedoksomil og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09DA",
"display": "Angiotensin II receptor blockers (ARBs) and diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09DA08",
"display": "C09DA08"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2006-05-12T00:00:00Z",
"display": "2006-05-12T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09DA08"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02C",
"display": "Antiadrenergic agents, peripherally acting",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Antiadrenergic agents, peripherally acting"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Antiadrenergika, perifert virkende"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02",
"display": "Antihypertensives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02C",
"display": "C02C"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02C"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09BA06",
"display": "Quinapril and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Quinapril and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kinapril og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09BA",
"display": "ACE inhibitors and diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09BA06",
"display": "C09BA06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09BA06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03AA01",
"display": "Bendroflumethiazide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bendroflumethiazide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bendroflumetiazid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03AA",
"display": "Thiazides, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03AA01",
"display": "C03AA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03AA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03EB02",
"display": "Bumetanide and potassium-sparing agents",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bumetanide and potassium-sparing agents"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bumetanid og kaliumsparende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03EB",
"display": "High-ceiling diuretics and potassium-sparing agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03EB02",
"display": "C03EB02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03EB02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08CA01",
"display": "Amlodipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Amlodipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Amlodipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08CA",
"display": "Dihydropyridine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08CA01",
"display": "C08CA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08CA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AD04",
"display": "Aluminium nicotinate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Aluminium nicotinate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Aluminiumnikotinat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AD",
"display": "Nicotinic acid and derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AD04",
"display": "C10AD04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AD04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BX06",
"display": "Atorvastatin, acetylsalicylic acid and ramipril",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Atorvastatin, acetylsalicylic acid and ramipril"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Atorvastatin, acetylsalisylsyre og ramipril"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10BX",
"display": "Lipid modifying agents in combination with other drugs"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BX06",
"display": "C10BX06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2014-02-20T00:00:00Z",
"display": "2014-02-20T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BX06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05BB01",
"display": "Monoethanolamine oleate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Monoethanolamine oleate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Monoetanolaminoleat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05BB",
"display": "Sclerosing agents for local injection"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05BB01",
"display": "C05BB01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05BB01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08CA15",
"display": "Benidipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Benidipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Benidipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08CA",
"display": "Dihydropyridine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08CA15",
"display": "C08CA15"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08CA15"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BX22",
"display": "Rosuvastatin and nebivolol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Rosuvastatin and nebivolol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Rosuvastatin og nebivolol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10BX",
"display": "Lipid modifying agents in combination with other drugs"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BX22",
"display": "C10BX22"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2024-11-19T00:00:00Z",
"display": "2024-11-19T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BX22"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01BG11",
"display": "Vernakalant",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Vernakalant"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Vernakalant"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01BG",
"display": "Other antiarrhythmics, class I and III"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01BG11",
"display": "C01BG11"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2010-12-13T00:00:00Z",
"display": "2010-12-13T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01BG11"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AE01",
"display": "Ergoloid mesylates",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ergoloid mesylates"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ergoloidmesylat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04AE",
"display": "Ergot alkaloids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AE01",
"display": "C04AE01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AE01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07AA03",
"display": "Pindolol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Pindolol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Pindolol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07AA",
"display": "Beta blocking agents, non-selective"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07AA03",
"display": "C07AA03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07AA03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03EB01",
"display": "Furosemide and potassium-sparing agents",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Furosemide and potassium-sparing agents"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Furosemid og kaliumsparende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03EB",
"display": "High-ceiling diuretics and potassium-sparing agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03EB01",
"display": "C03EB01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03EB01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03DB02",
"display": "Triamterene",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Triamterene"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Triamteren"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03DB",
"display": "Other potassium-sparing agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03DB02",
"display": "C03DB02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03DB02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02LA08",
"display": "Rauwolfia alkaloids, whole root and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Rauwolfia alkaloids, whole root and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Rauwolfiaalkaloider, hel rot og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02LA",
"display": "Rauwolfia alkaloids and diuretics in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02LA08",
"display": "C02LA08"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02LA08"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09DB07",
"display": "Candesartan and amlodipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Candesartan and amlodipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kandesartan og amlodipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09DB",
"display": "Angiotensin II receptor blockers (ARBs) and calcium channel blockers"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09DB07",
"display": "C09DB07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2013-12-10T00:00:00Z",
"display": "2013-12-10T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09DB07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07FB12",
"display": "Nebivolol and amlodipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Nebivolol and amlodipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nebivolol og amlodipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07FB",
"display": "Beta blocking agents and calcium channel blockers"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07FB12",
"display": "C07FB12"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2014-02-20T00:00:00Z",
"display": "2014-02-20T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07FB12"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DX05",
"display": "Carbocromen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Carbocromen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Karbokromen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DX",
"display": "Other vasodilators used in cardiac diseases"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DX05",
"display": "C01DX05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DX05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09AA16",
"display": "Imidapril",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Imidapril"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Imidapril"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09AA",
"display": "ACE inhibitors, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09AA16",
"display": "C09AA16"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09AA16"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DX03",
"display": "Oxyfedrine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Oxyfedrine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Oksyfedrin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DX",
"display": "Other vasodilators used in cardiac diseases"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DX03",
"display": "C01DX03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DX03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01AB51",
"display": "Proscillaridin, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Proscillaridin, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Proskillaridin, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01AB",
"display": "Scilla glycosides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01AB51",
"display": "C01AB51"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01AB51"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07",
"display": "Beta blocking agents",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Beta blocking agents"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Betablokkere"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C",
"display": "Cardiovascular system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07",
"display": "C07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09AA06",
"display": "Quinapril",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Quinapril"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kinapril"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09AA",
"display": "ACE inhibitors, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09AA06",
"display": "C09AA06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09AA06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DA14",
"display": "Isosorbide mononitrate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Isosorbide mononitrate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Isosorbidmononitrat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DA",
"display": "Organic nitrates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DA14",
"display": "C01DA14"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DA14"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03BA82",
"display": "Clorexolone, comb. with psycholeptics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Clorexolone, comb. with psycholeptics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kloreksolon, kombinasjoner med psykoleptika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03BA",
"display": "Sulfonamides, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03BA82",
"display": "C03BA82"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03BA82"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03CX",
"display": "Other high-ceiling diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other high-ceiling diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre high-ceiling diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03C",
"display": "High-ceiling diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03CX",
"display": "C03CX"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03CX"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03XA01",
"display": "Tolvaptan",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Tolvaptan"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tolvaptan"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03XA",
"display": "Vasopressin antagonists"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03XA01",
"display": "C03XA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2009-03-20T00:00:00Z",
"display": "2009-03-20T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03XA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DA02",
"display": "Glyceryl trinitrate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Glyceryl trinitrate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Glyseryltrinitrat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DA",
"display": "Organic nitrates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DA02",
"display": "C01DA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CX",
"display": "Other cardiac stimulants",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other cardiac stimulants"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre hjertestimulerende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01C",
"display": "Cardiac stimulants excl. cardiac glycosides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CX",
"display": "C01CX"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CX"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07CA17",
"display": "Bopindolol and other diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bopindolol and other diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bopindolol og andre diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07CA",
"display": "Beta blocking agents, non-selective, and other diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07CA17",
"display": "C07CA17"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07CA17"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CA13",
"display": "Prenalterol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Prenalterol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Prenalterol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CA",
"display": "Adrenergic and dopaminergic agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CA13",
"display": "C01CA13"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CA13"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07AB11",
"display": "S-atenolol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "S-atenolol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "S-atenolol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07AB",
"display": "Beta blocking agents, selective"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07AB11",
"display": "C07AB11"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07AB11"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03CB01",
"display": "Furosemide and potassium",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Furosemide and potassium"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Furosemid og kalium"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03CB",
"display": "Sulfonamides and potassium in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03CB01",
"display": "C03CB01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03CB01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09CA09",
"display": "Azilsartan medoxomil",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Azilsartan medoxomil"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Azilsartanmedoksomil"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09CA",
"display": "Angiotensin II receptor blockers (ARBs), plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09CA09",
"display": "C09CA09"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2012-01-01T00:00:00Z",
"display": "2012-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09CA09"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AA02",
"display": "Lovastatin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Lovastatin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Lovastatin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AA",
"display": "HMG CoA reductase inhibitors"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AA02",
"display": "C10AA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08GA01",
"display": "Nifedipine and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Nifedipine and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nifedipin og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08GA",
"display": "Calcium channel blockers and diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08GA01",
"display": "C08GA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08GA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08EX",
"display": "Other non-selective calcium channel blockers",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other non-selective calcium channel blockers"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre ikke-selektive kalsiumantagonister"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08E",
"display": "Non-selective calcium channel blockers"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08EX",
"display": "C08EX"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08EX"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02BA",
"display": "Sulfonium derivatives",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Sulfonium derivatives"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Sulfoniumderivater"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02B",
"display": "Antiadrenergic agents, ganglion-blocking"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02BA",
"display": "C02BA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02BA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09DB04",
"display": "Telmisartan and amlodipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Telmisartan and amlodipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Telmisartan og amlodipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09DB",
"display": "Angiotensin II receptor blockers (ARBs) and calcium channel blockers"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09DB04",
"display": "C09DB04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2010-01-01T00:00:00Z",
"display": "2010-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09DB04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03AB07",
"display": "Cyclopenthiazide and potassium",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Cyclopenthiazide and potassium"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Cyklopentiazid og kalium"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03AB",
"display": "Thiazides and potassium in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03AB07",
"display": "C03AB07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03AB07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01BB04",
"display": "Aprindine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Aprindine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Aprindin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01BB",
"display": "Antiarrhythmics, class Ib"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01BB04",
"display": "C01BB04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01BB04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CE02",
"display": "Milrinone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Milrinone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Milrinon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CE",
"display": "Phosphodiesterase inhibitors"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CE02",
"display": "C01CE02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CE02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DB01",
"display": "Flosequinan",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Flosequinan"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Flosekinan"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DB",
"display": "Quinolone vasodilators"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DB01",
"display": "C01DB01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DB01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03CX01",
"display": "Etozolin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Etozolin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Etozolin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03CX",
"display": "Other high-ceiling diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03CX01",
"display": "C03CX01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03CX01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07AA",
"display": "Beta blocking agents, non-selective",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Beta blocking agents, non-selective"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Betablokkere, ikke-selektive"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07A",
"display": "Beta blocking agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07AA",
"display": "C07AA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07AA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08CA14",
"display": "Cilnidipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Cilnidipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Cilnidipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08CA",
"display": "Dihydropyridine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08CA14",
"display": "C08CA14"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08CA14"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02A",
"display": "Antiadrenergic agents, centrally acting",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Antiadrenergic agents, centrally acting"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Antiadrenergika, sentralt virkende"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02",
"display": "Antihypertensives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02A",
"display": "C02A"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02A"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07AB02",
"display": "Metoprolol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Metoprolol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Metoprolol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07AB",
"display": "Beta blocking agents, selective"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07AB02",
"display": "C07AB02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07AB02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02KC01",
"display": "Pargyline",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Pargyline"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Pargylin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02KC",
"display": "MAO inhibitors"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02KC01",
"display": "C02KC01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02KC01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03BB04",
"display": "Chlortalidone and potassium",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Chlortalidone and potassium"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Klortalidon og kalium"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03BB",
"display": "Sulfonamides and potassium in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03BB04",
"display": "C03BB04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03BB04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08DA03",
"display": "Etripamil",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Etripamil"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Etripamil"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08DA",
"display": "Phenylalkylamine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08DA03",
"display": "C08DA03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2024-11-19T00:00:00Z",
"display": "2024-11-19T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08DA03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09CA10",
"display": "Fimasartan",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Fimasartan"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fimasartan"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09CA",
"display": "Angiotensin II receptor blockers (ARBs), plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09CA10",
"display": "C09CA10"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2014-07-15T00:00:00Z",
"display": "2014-07-15T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09CA10"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07AB03",
"display": "Atenolol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Atenolol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Atenolol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07AB",
"display": "Beta blocking agents, selective"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07AB03",
"display": "C07AB03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07AB03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DX02",
"display": "Prenylamine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Prenylamine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Prenylamin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DX",
"display": "Other vasodilators used in cardiac diseases"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DX02",
"display": "C01DX02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DX02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01EA01",
"display": "Alprostadil",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Alprostadil"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Alprostadil"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01EA",
"display": "Prostaglandins"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01EA01",
"display": "C01EA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01EA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09BA05",
"display": "Ramipril and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ramipril and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ramipril og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09BA",
"display": "ACE inhibitors and diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09BA05",
"display": "C09BA05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09BA05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DX14",
"display": "Cinepazet",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Cinepazet"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Cinepazet"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DX",
"display": "Other vasodilators used in cardiac diseases"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DX14",
"display": "C01DX14"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DX14"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AA03",
"display": "Pravastatin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Pravastatin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Pravastatin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AA",
"display": "HMG CoA reductase inhibitors"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AA03",
"display": "C10AA03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AA03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01BB02",
"display": "Mexiletine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Mexiletine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Meksiletin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01BB",
"display": "Antiarrhythmics, class Ib"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01BB02",
"display": "C01BB02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01BB02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AA08",
"display": "Pitavastatin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Pitavastatin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Pitavastatin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AA",
"display": "HMG CoA reductase inhibitors"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AA08",
"display": "C10AA08"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AA08"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AX17",
"display": "Evinacumab",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Evinacumab"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Evinakumab"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AX",
"display": "Other lipid modifying agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AX17",
"display": "C10AX17"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2021-03-04T00:00:00Z",
"display": "2021-03-04T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AX17"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CA18",
"display": "Octopamine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Octopamine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Oktopamin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CA",
"display": "Adrenergic and dopaminergic agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CA18",
"display": "C01CA18"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CA18"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03BA12",
"display": "Clorexolone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Clorexolone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kloreksolon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03BA",
"display": "Sulfonamides, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03BA12",
"display": "C03BA12"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03BA12"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08DA02",
"display": "Gallopamil",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Gallopamil"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Gallopamil"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08DA",
"display": "Phenylalkylamine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08DA02",
"display": "C08DA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08DA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AD03",
"display": "Pentoxifylline",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Pentoxifylline"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Pentoksyfyllin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04AD",
"display": "Purine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AD03",
"display": "C04AD03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AD03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07BA02",
"display": "Oxprenolol and thiazides",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Oxprenolol and thiazides"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Oksprenolol og tiazider"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07BA",
"display": "Beta blocking agents, non-selective, and thiazides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07BA02",
"display": "C07BA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07BA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02DB02",
"display": "Hydralazine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Hydralazine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Hydralazin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02DB",
"display": "Hydrazinophthalazine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02DB02",
"display": "C02DB02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02DB02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02LC05",
"display": "Moxonidine and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Moxonidine and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Moksonidin og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02LC",
"display": "Imidazoline receptor agonists in combination with diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02LC05",
"display": "C02LC05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02LC05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09AA04",
"display": "Perindopril",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Perindopril"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Perindopril"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09AA",
"display": "ACE inhibitors, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09AA04",
"display": "C09AA04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09AA04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01BD02",
"display": "Bretylium tosilate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bretylium tosilate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bretyliumtosilat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01BD",
"display": "Antiarrhythmics, class III"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01BD02",
"display": "C01BD02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01BD02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07AB10",
"display": "Epanolol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Epanolol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Epanolol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07AB",
"display": "Beta blocking agents, selective"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07AB10",
"display": "C07AB10"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07AB10"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01BA12",
"display": "Lorajmine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Lorajmine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Lorajmin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01BA",
"display": "Antiarrhythmics, class Ia"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01BA12",
"display": "C01BA12"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01BA12"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AA",
"display": "2-amino-1-phenylethanol derivatives",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "2-amino-1-phenylethanol derivatives"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Derivater av 2-amino-1-fenyletanol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04A",
"display": "Peripheral vasodilators"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AA",
"display": "C04AA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01BA71",
"display": "Quinidine, combinations with psycholeptics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Quinidine, combinations with psycholeptics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kinidin, kombinasjoner med psykoleptika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01BA",
"display": "Antiarrhythmics, class Ia"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01BA71",
"display": "C01BA71"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01BA71"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09DX07",
"display": "Irbesartan, amlodipine and hydrochlorothiazide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Irbesartan, amlodipine and hydrochlorothiazide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Irbesartan, amlodipin og hydroklortiazid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09DX",
"display": "Angiotensin II receptor blockers (ARBs), other combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09DX07",
"display": "C09DX07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2019-04-09T00:00:00Z",
"display": "2019-04-09T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09DX07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AX13",
"display": "Evolocumab",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Evolocumab"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Evolokumab"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AX",
"display": "Other lipid modifying agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AX13",
"display": "C10AX13"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2014-07-15T00:00:00Z",
"display": "2014-07-15T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AX13"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03CC01",
"display": "Etacrynic acid",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Etacrynic acid"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Etakrynsyre"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03CC",
"display": "Aryloxyacetic acid derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03CC01",
"display": "C03CC01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03CC01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AC02",
"display": "Nicotinyl alcohol (pyridylcarbinol)",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Nicotinyl alcohol (pyridylcarbinol)"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nikotinylalkohol (pyridylkarbinol)"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04AC",
"display": "Nicotinic acid and derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AC02",
"display": "C04AC02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AC02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01EB05",
"display": "Creatinolfosfate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Creatinolfosfate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kreatinolfosfat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01EB",
"display": "Other cardiac preparations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01EB05",
"display": "C01EB05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01EB05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07AB09",
"display": "Esmolol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Esmolol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Esmolol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07AB",
"display": "Beta blocking agents, selective"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07AB09",
"display": "C07AB09"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07AB09"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07DA06",
"display": "Timolol, thiazides and other diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Timolol, thiazides and other diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Timolol, tiazider og andre diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07DA",
"display": "Beta blocking agents, non-selective, thiazides and other diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07DA06",
"display": "C07DA06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07DA06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01AA04",
"display": "Digitoxin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Digitoxin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Digitoksin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01AA",
"display": "Digitalis glycosides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01AA04",
"display": "C01AA04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01AA04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CA07",
"display": "Dobutamine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Dobutamine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Dobutamin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CA",
"display": "Adrenergic and dopaminergic agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CA07",
"display": "C01CA07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CA07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01C",
"display": "Cardiac stimulants excl. cardiac glycosides",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Cardiac stimulants excl. cardiac glycosides"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Hjertestimulerende midler ekskl. hjerteglykosider"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01",
"display": "Cardiac therapy"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01C",
"display": "C01C"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01C"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02CA04",
"display": "Doxazosin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Doxazosin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Doksazosin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02CA",
"display": "Alpha-adrenoreceptor antagonists"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02CA04",
"display": "C02CA04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02CA04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AD01",
"display": "Pentifylline",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Pentifylline"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Pentifyllin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04AD",
"display": "Purine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AD01",
"display": "C04AD01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AD01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AF01",
"display": "Kallidinogenase",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Kallidinogenase"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kallidinogenase"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04AF",
"display": "Enzymes"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AF01",
"display": "C04AF01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AF01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CA26",
"display": "Ephedrine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ephedrine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Efedrin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CA",
"display": "Adrenergic and dopaminergic agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CA26",
"display": "C01CA26"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2010-12-13T00:00:00Z",
"display": "2010-12-13T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CA26"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09CA07",
"display": "Telmisartan",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Telmisartan"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Telmisartan"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09CA",
"display": "Angiotensin II receptor blockers (ARBs), plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09CA07",
"display": "C09CA07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09CA07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01BD01",
"display": "Amiodarone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Amiodarone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Amiodaron"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01BD",
"display": "Antiarrhythmics, class III"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01BD01",
"display": "C01BD01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01BD01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DX19",
"display": "Nesiritide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Nesiritide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nesiritid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DX",
"display": "Other vasodilators used in cardiac diseases"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DX19",
"display": "C01DX19"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DX19"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08CA16",
"display": "Clevidipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Clevidipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Klevidipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08CA",
"display": "Dihydropyridine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08CA16",
"display": "C08CA16"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2011-01-01T00:00:00Z",
"display": "2011-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08CA16"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02DB04",
"display": "Cadralazine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Cadralazine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kadralazin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02DB",
"display": "Hydrazinophthalazine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02DB04",
"display": "C02DB04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02DB04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AE",
"display": "Ergot alkaloids",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ergot alkaloids"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Sekalealkaloider"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04A",
"display": "Peripheral vasodilators"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AE",
"display": "C04AE"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AE"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CA24",
"display": "Epinephrine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Epinephrine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Adrenalin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CA",
"display": "Adrenergic and dopaminergic agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CA24",
"display": "C01CA24"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CA24"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AC01",
"display": "Colestyramine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Colestyramine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kolestyramin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AC",
"display": "Bile acid sequestrants"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AC01",
"display": "C10AC01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AC01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09B",
"display": "ACE inhibitors, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "ACE inhibitors, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "ACE-hemmere, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09",
"display": "Agents acting on the renin-angiotensin system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09B",
"display": "C09B"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09B"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05BB03",
"display": "Invert sugar",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Invert sugar"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Invertose"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05BB",
"display": "Sclerosing agents for local injection"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05BB03",
"display": "C05BB03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05BB03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07AB14",
"display": "Landiolol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Landiolol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Landiolol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07AB",
"display": "Beta blocking agents, selective"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07AB14",
"display": "C07AB14"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2016-02-09T00:00:00Z",
"display": "2016-02-09T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07AB14"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03C",
"display": "High-ceiling diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "High-ceiling diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "High-ceiling diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03",
"display": "Diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03C",
"display": "C03C"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03C"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DX",
"display": "Other vasodilators used in cardiac diseases",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other vasodilators used in cardiac diseases"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre kardilaterende midler ved hjertesykdommer"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01D",
"display": "Vasodilatators used in cardiac disease"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DX",
"display": "C01DX"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DX"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03CC",
"display": "Aryloxyacetic acid derivatives",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Aryloxyacetic acid derivatives"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Aryloksyeddiksyrederivater"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03C",
"display": "High-ceiling diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03CC",
"display": "C03CC"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03CC"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09DX06",
"display": "Candesartan, amlodipine and hydrochlorothiazide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Candesartan, amlodipine and hydrochlorothiazide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kandesartan, amlodipin og hydroklortiazid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09DX",
"display": "Angiotensin II receptor blockers (ARBs), other combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09DX06",
"display": "C09DX06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2018-07-10T00:00:00Z",
"display": "2018-07-10T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09DX06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03EA02",
"display": "Trichlormethiazide and potassium-sparing agents",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Trichlormethiazide and potassium-sparing agents"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Triklormetiazid og kaliumsparende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03EA",
"display": "Low-ceiling diuretics and potassium-sparing agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03EA02",
"display": "C03EA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03EA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05BB02",
"display": "Polidocanol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Polidocanol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Polidokanol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05BB",
"display": "Sclerosing agents for local injection"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05BB02",
"display": "C05BB02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05BB02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07AB06",
"display": "Bevantolol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bevantolol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bevantolol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07AB",
"display": "Beta blocking agents, selective"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07AB06",
"display": "C07AB06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07AB06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02KN01",
"display": "Aprocitentan",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Aprocitentan"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Aprocitentan"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02KN",
"display": "Other antihypertensives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02KN01",
"display": "C02KN01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2024-05-10T00:00:00Z",
"display": "2024-05-10T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02KN01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09AA03",
"display": "Lisinopril",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Lisinopril"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Lisinopril"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09AA",
"display": "ACE inhibitors, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09AA03",
"display": "C09AA03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09AA03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09AA14",
"display": "Temocapril",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Temocapril"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Temokapril"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09AA",
"display": "ACE inhibitors, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09AA14",
"display": "C09AA14"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09AA14"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AX20",
"display": "Buflomedil",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Buflomedil"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Buflomedil"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04AX",
"display": "Other peripheral vasodilators"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AX20",
"display": "C04AX20"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AX20"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09AA07",
"display": "Benazepril",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Benazepril"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Benazepril"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09AA",
"display": "ACE inhibitors, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09AA07",
"display": "C09AA07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09AA07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01BC07",
"display": "Lorcainide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Lorcainide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Lorkainid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01BC",
"display": "Antiarrhythmics, class Ic"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01BC07",
"display": "C01BC07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01BC07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09DB03",
"display": "Angiotensin II antagonists and calcium channel blockers, including combinations with diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Angiotensin II antagonists and calcium channel blockers, including combinations with diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Angiotensin II antagonists and calcium channel blockers, including combinations with diuretics"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09DB",
"display": "Angiotensin II receptor blockers (ARBs) and calcium channel blockers"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09DB03",
"display": "C09DB03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2009-05-06T00:00:00Z",
"display": "2009-05-06T00:00:00Z"
}
},
{
"code": "toDate",
"valueCoding": {
"code": "2014-07-01T00:00:00Z",
"display": "2014-07-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09DB03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Slettet",
"display": "Slettet"
}
}
]
},
{
"code": "C10AA01",
"display": "Simvastatin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Simvastatin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Simvastatin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AA",
"display": "HMG CoA reductase inhibitors"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AA01",
"display": "C10AA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08CA05",
"display": "Nifedipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Nifedipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nifedipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08CA",
"display": "Dihydropyridine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08CA05",
"display": "C08CA05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08CA05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05AA06",
"display": "Fluorometholone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Fluorometholone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fluorometolon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05AA",
"display": "Corticosteroids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05AA06",
"display": "C05AA06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05AA06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03EA13",
"display": "Bendroflumethiazide and potassium-sparing agents",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bendroflumethiazide and potassium-sparing agents"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bendroflumetiazid og kaliumsparende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03EA",
"display": "Low-ceiling diuretics and potassium-sparing agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03EA13",
"display": "C03EA13"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03EA13"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05CA02",
"display": "Monoxerutin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Monoxerutin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Monokserutin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05CA",
"display": "Bioflavonoids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05CA02",
"display": "C05CA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05CA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CA08",
"display": "Oxedrine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Oxedrine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Oksedrin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CA",
"display": "Adrenergic and dopaminergic agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CA08",
"display": "C01CA08"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CA08"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CA51",
"display": "Etilefrine, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Etilefrine, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Etilefrin, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CA",
"display": "Adrenergic and dopaminergic agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CA51",
"display": "C01CA51"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CA51"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01BA05",
"display": "Ajmaline",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ajmaline"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ajmalin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01BA",
"display": "Antiarrhythmics, class Ia"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01BA05",
"display": "C01BA05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01BA05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01EB02",
"display": "Camphora",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Camphora"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kamfer"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01EB",
"display": "Other cardiac preparations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01EB02",
"display": "C01EB02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01EB02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09AA10",
"display": "Trandolapril",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Trandolapril"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Trandolapril"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09AA",
"display": "ACE inhibitors, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09AA10",
"display": "C09AA10"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09AA10"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07FX",
"display": "Beta blocking agents, other combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Beta blocking agents, other combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Betablokkere, andre kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07F",
"display": "Beta blocking agents, other combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07FX",
"display": "C07FX"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2017-06-14T00:00:00Z",
"display": "2017-06-14T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07FX"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AE54",
"display": "Dihydroergocristine, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Dihydroergocristine, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Dihydroergokristin, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04AE",
"display": "Ergot alkaloids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AE54",
"display": "C04AE54"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AE54"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09DX02",
"display": "Valsartan and aliskiren",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Valsartan and aliskiren"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Valsartan og aliskiren"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09DX",
"display": "Angiotensin II receptor blockers (ARBs), other combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09DX02",
"display": "C09DX02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2010-01-01T00:00:00Z",
"display": "2010-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09DX02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07AA14",
"display": "Mepindolol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Mepindolol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Mepindolol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07AA",
"display": "Beta blocking agents, non-selective"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07AA14",
"display": "C07AA14"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07AA14"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BA11",
"display": "Pravastatin and ezetimibe",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Pravastatin and ezetimibe"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Pravastatin og ezetimib"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10BA",
"display": "Combinations of various lipid modifying agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BA11",
"display": "C10BA11"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2021-03-04T00:00:00Z",
"display": "2021-03-04T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BA11"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AD03",
"display": "Nicofuranose",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Nicofuranose"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nikofuranose"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AD",
"display": "Nicotinic acid and derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AD03",
"display": "C10AD03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AD03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03BB05",
"display": "Mefruside and potassium",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Mefruside and potassium"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Mefrusid og kalium"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03BB",
"display": "Sulfonamides and potassium in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03BB05",
"display": "C03BB05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03BB05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02CC03",
"display": "Guanoxan",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Guanoxan"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Guanoksan"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02CC",
"display": "Guanidine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02CC03",
"display": "C02CC03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02CC03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07AG01",
"display": "Labetalol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Labetalol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Labetalol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07AG",
"display": "Alpha and beta blocking agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07AG01",
"display": "C07AG01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07AG01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AF",
"display": "Enzymes",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Enzymes"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Enzymer"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04A",
"display": "Peripheral vasodilators"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AF",
"display": "C04AF"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AF"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03AX",
"display": "Thiazides, combinations with other drugs",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Thiazides, combinations with other drugs"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tiazider i kombinasjon med andre midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03A",
"display": "Low-ceiling diuretics, thiazides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03AX",
"display": "C03AX"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03AX"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03AB05",
"display": "Polythiazide and potassium",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Polythiazide and potassium"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Polytiazid og kalium"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03AB",
"display": "Thiazides and potassium in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03AB05",
"display": "C03AB05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03AB05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BX19",
"display": "Atorvastatin, amlodipine and candesartan",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Atorvastatin, amlodipine and candesartan"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Atorvastatin, amlodipin og kandesartan"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10BX",
"display": "Lipid modifying agents in combination with other drugs"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BX19",
"display": "C10BX19"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2022-01-31T00:00:00Z",
"display": "2022-01-31T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BX19"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05AA04",
"display": "Prednisolone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Prednisolone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Prednisolon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05AA",
"display": "Corticosteroids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05AA04",
"display": "C05AA04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05AA04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07AA15",
"display": "Carteolol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Carteolol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Karteolol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07AA",
"display": "Beta blocking agents, non-selective"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07AA15",
"display": "C07AA15"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07AA15"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05AA05",
"display": "Betamethasone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Betamethasone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Betametason"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05AA",
"display": "Corticosteroids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05AA05",
"display": "C05AA05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05AA05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CA14",
"display": "Dopexamine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Dopexamine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Dopeksamin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CA",
"display": "Adrenergic and dopaminergic agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CA14",
"display": "C01CA14"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CA14"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09DX03",
"display": "Olmesartan medoxomil, amlodipine and hydrochlorothiazide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Olmesartan medoxomil, amlodipine and hydrochlorothiazide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Olmesartanmedoksomil, amlodipin og hydroklortiazid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09DX",
"display": "Angiotensin II receptor blockers (ARBs), other combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09DX03",
"display": "C09DX03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2011-01-01T00:00:00Z",
"display": "2011-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09DX03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01AA52",
"display": "Acetyldigoxin, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Acetyldigoxin, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Acetyldigoksin, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01AA",
"display": "Digitalis glycosides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01AA52",
"display": "C01AA52"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01AA52"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09DX04",
"display": "Valsartan and sacubitril",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Valsartan and sacubitril"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Valsartan og sakubitril"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09DX",
"display": "Angiotensin II receptor blockers (ARBs), other combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09DX04",
"display": "C09DX04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2015-07-06T00:00:00Z",
"display": "2015-07-06T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09DX04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08EA01",
"display": "Fendiline",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Fendiline"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fendilin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08EA",
"display": "Phenylalkylamine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08EA01",
"display": "C08EA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08EA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AB10",
"display": "Clofibride",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Clofibride"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Klofibrid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AB",
"display": "Fibrates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AB10",
"display": "C10AB10"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AB10"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02N",
"display": "COMBINATIONS OF ANTIHYPERTENSIVES IN ATC-GR. C02",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "COMBINATIONS OF ANTIHYPERTENSIVES IN ATC-GR. C02"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kombinasjoner av antihypertensiva i ATC-gr. C02"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02",
"display": "Antihypertensives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02N",
"display": "C02N"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02N"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AX09",
"display": "Ezetimibe",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ezetimibe"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ezetimib"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AX",
"display": "Other lipid modifying agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AX09",
"display": "C10AX09"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2003-05-06T00:00:00Z",
"display": "2003-05-06T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AX09"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07BG",
"display": "Alpha and beta blocking agents and thiazides",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Alpha and beta blocking agents and thiazides"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Alfa- og betablokkere og tiazider"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07B",
"display": "Beta blocking agents and thiazider"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07BG",
"display": "C07BG"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07BG"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03AA02",
"display": "Hydroflumethiazide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Hydroflumethiazide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Hydroflumetiazid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03AA",
"display": "Thiazides, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03AA02",
"display": "C03AA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03AA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09AA05",
"display": "Ramipril",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ramipril"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ramipril"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09AA",
"display": "ACE inhibitors, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09AA05",
"display": "C09AA05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09AA05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DA63",
"display": "Eritrityl tetranitrate, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Eritrityl tetranitrate, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Erytritoltetranitrat, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DA",
"display": "Organic nitrates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DA63",
"display": "C01DA63"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DA63"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07A",
"display": "Beta blocking agents",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Beta blocking agents"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Betablokkere"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07",
"display": "Beta blocking agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07A",
"display": "C07A"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07A"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AB01",
"display": "Clofibrate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Clofibrate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Klofibrat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AB",
"display": "Fibrates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AB01",
"display": "C10AB01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AB01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02LB01",
"display": "Methyldopa (levorotatory) and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Methyldopa (levorotatory) and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Metyldopa (venstredreiende) og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02LB",
"display": "Methyldopa and diuretics in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02LB01",
"display": "C02LB01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02LB01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08CX01",
"display": "Mibefradil",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Mibefradil"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Mibefradil"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08CX",
"display": "Other selective calcium channel blockers with mainly vascular effects"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08CX01",
"display": "C08CX01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08CX01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05CA53",
"display": "Diosmin, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Diosmin, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Diosmin, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05CA",
"display": "Bioflavonoids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05CA53",
"display": "C05CA53"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05CA53"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DA59",
"display": "Trolnitrate, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Trolnitrate, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Trolnitrat, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DA",
"display": "Organic nitrates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DA59",
"display": "C01DA59"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DA59"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03AB09",
"display": "Cyclothiazide and potassium",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Cyclothiazide and potassium"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Cyklotiazid og kalium"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03AB",
"display": "Thiazides and potassium in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03AB09",
"display": "C03AB09"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03AB09"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07C",
"display": "Beta blocking agents and other diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Beta blocking agents and other diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Betablokkere og andre diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07",
"display": "Beta blocking agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07C",
"display": "C07C"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07C"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07CA",
"display": "Beta blocking agents, non-selective, and other diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Beta blocking agents, non-selective, and other diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Betablokkere, ikke-selektive, og andre diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07C",
"display": "Beta blocking agents and other diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07CA",
"display": "C07CA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07CA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CE04",
"display": "Bucladesine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bucladesine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bukladesin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CE",
"display": "Phosphodiesterase inhibitors"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CE04",
"display": "C01CE04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CE04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03AA06",
"display": "Trichlormethiazide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Trichlormethiazide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Triklormetiazid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03AA",
"display": "Thiazides, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03AA06",
"display": "C03AA06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03AA06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CX08",
"display": "Levosimendan",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Levosimendan"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Levosimendan"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CX",
"display": "Other cardiac stimulants"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CX08",
"display": "C01CX08"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CX08"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02DC01",
"display": "Minoxidil",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Minoxidil"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Minoksidil"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02DC",
"display": "Pyrimidine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02DC01",
"display": "C02DC01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02DC01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02AC",
"display": "Imidazoline receptor agonists",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Imidazoline receptor agonists"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Imidazolinreseptoragonister"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02A",
"display": "Antiadrenergic agents, centrally acting"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02AC",
"display": "C02AC"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02AC"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05BX01",
"display": "Calcium dobesilate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Calcium dobesilate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kalsiumdobesilat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05BX",
"display": "Other sclerosing agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05BX01",
"display": "C05BX01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05BX01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08GA02",
"display": "Amlodipine and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Amlodipine and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Amlodipin og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08GA",
"display": "Calcium channel blockers and diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08GA02",
"display": "C08GA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2013-12-10T00:00:00Z",
"display": "2013-12-10T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08GA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03AA03",
"display": "Hydrochlorothiazide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Hydrochlorothiazide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Hydroklortiazid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03AA",
"display": "Thiazides, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03AA03",
"display": "C03AA03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03AA03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CX09",
"display": "Angiotensin II",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Angiotensin II"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Angiotensin II"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CX",
"display": "Other cardiac stimulants"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CX09",
"display": "C01CX09"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2018-07-10T00:00:00Z",
"display": "2018-07-10T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CX09"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09DB08",
"display": "Valsartan and lercanidipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Valsartan and lercanidipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Valsartan og lerkanidipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09DB",
"display": "Angiotensin II receptor blockers (ARBs) and calcium channel blockers"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09DB08",
"display": "C09DB08"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2015-07-06T00:00:00Z",
"display": "2015-07-06T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09DB08"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03BA10",
"display": "Xipamide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Xipamide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Xipamid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03BA",
"display": "Sulfonamides, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03BA10",
"display": "C03BA10"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03BA10"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AX10",
"display": "Alipogene tiparvovec",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Alipogene tiparvovec"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Alipogentiparvovek"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AX",
"display": "Other lipid modifying agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AX10",
"display": "C10AX10"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2009-03-20T00:00:00Z",
"display": "2009-03-20T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AX10"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03BA05",
"display": "Mefruside",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Mefruside"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Mefrusid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03BA",
"display": "Sulfonamides, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03BA05",
"display": "C03BA05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03BA05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03CA",
"display": "Sulfonamides, plain",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Sulfonamides, plain"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Sulfonamider, usammensatte"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03C",
"display": "High-ceiling diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03CA",
"display": "C03CA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03CA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03BX03",
"display": "Cicletanine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Cicletanine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Sikletanin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03BX",
"display": "Other low-ceiling diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03BX03",
"display": "C03BX03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03BX03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05B",
"display": "Antivaricose therapy",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Antivaricose therapy"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Varicemidler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05",
"display": "Vasoprotectives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05B",
"display": "C05B"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05B"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AD06",
"display": "Acipimox",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Acipimox"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Acipimoks"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AD",
"display": "Nicotinic acid and derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AD06",
"display": "C10AD06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AD06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08CA12",
"display": "Barnidipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Barnidipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Barnidipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08CA",
"display": "Dihydropyridine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08CA12",
"display": "C08CA12"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08CA12"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01AA07",
"display": "Deslanoside",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Deslanoside"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Deslanosid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01AA",
"display": "Digitalis glycosides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01AA07",
"display": "C01AA07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01AA07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DB",
"display": "Quinolone vasodilators",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Quinolone vasodilators"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kinolon kardilaterende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01D",
"display": "Vasodilatators used in cardiac disease"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DB",
"display": "C01DB"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DB"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07BB",
"display": "Beta blocking agents, selective, and thiazides",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Beta blocking agents, selective, and thiazides"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Betablokkere, selektive, og tiazider"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07B",
"display": "Beta blocking agents and thiazider"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07BB",
"display": "C07BB"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07BB"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03AB02",
"display": "Hydroflumethiazide and potassium",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Hydroflumethiazide and potassium"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Hydroflumetiazid og kalium"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03AB",
"display": "Thiazides and potassium in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03AB02",
"display": "C03AB02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03AB02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07FX01",
"display": "Propranolol and other combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Propranolol and other combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Propranolol og andre kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07FX",
"display": "Beta blocking agents, other combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07FX01",
"display": "C07FX01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07FX01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CA25",
"display": "Amezinium metilsulfate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Amezinium metilsulfate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ameziniummetylsulfat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CA",
"display": "Adrenergic and dopaminergic agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CA25",
"display": "C01CA25"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2011-01-01T00:00:00Z",
"display": "2011-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CA25"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03CB",
"display": "Sulfonamides and potassium in combination",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Sulfonamides and potassium in combination"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Sulfonamider og kalium i kombinasjon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03C",
"display": "High-ceiling diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03CB",
"display": "C03CB"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03CB"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02AC05",
"display": "Moxonidine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Moxonidine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Moksonidin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02AC",
"display": "Imidazoline receptor agonists"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02AC05",
"display": "C02AC05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02AC05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09XX",
"display": "Other agents acting on the renin-angiotensin system",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other agents acting on the renin-angiotensin system"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre midler virkende på renin-angiotensin-systemet"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09X",
"display": "Other agents acting on the renin-angiotensin system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09XX",
"display": "C09XX"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2024-12-08T00:00:00Z",
"display": "2024-12-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09XX"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BX20",
"display": "Rosuvastatin and telmisartan",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Rosuvastatin and telmisartan"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Rosuvastatin og telmisartan"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10BX",
"display": "Lipid modifying agents in combination with other drugs"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BX20",
"display": "C10BX20"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2023-12-05T00:00:00Z",
"display": "2023-12-05T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BX20"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02LA07",
"display": "Bietaserpine and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bietaserpine and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bietaserpin og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02LA",
"display": "Rauwolfia alkaloids and diuretics in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02LA07",
"display": "C02LA07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02LA07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01AA02",
"display": "Acetyldigoxin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Acetyldigoxin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Acetyldigoksin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01AA",
"display": "Digitalis glycosides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01AA02",
"display": "C01AA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01AA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02LF01",
"display": "Guanethidine and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Guanethidine and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Guanetidin og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02LF",
"display": "Guanidine derivatives and diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02LF01",
"display": "C02LF01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02LF01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02AA07",
"display": "Bietaserpine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bietaserpine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bietaserpin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02AA",
"display": "Rauwolfia alkaloids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02AA07",
"display": "C02AA07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02AA07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05AX01",
"display": "Aluminium preparations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Aluminium preparations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Aluminiummidler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05AX",
"display": "Other agents for treatment of hemorrhoids and anal fissures for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05AX01",
"display": "C05AX01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05AX01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BA04",
"display": "Simvastatin and fenofibrate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Simvastatin and fenofibrate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Simvastatin og fenofibrat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10BA",
"display": "Combinations of various lipid modifying agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BA04",
"display": "C10BA04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2013-01-28T00:00:00Z",
"display": "2013-01-28T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BA04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08CA",
"display": "Dihydropyridine derivatives",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Dihydropyridine derivatives"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Dihydropyridinderivater"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08C",
"display": "Selective calcium channel blockers with mainly vascular effects"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08CA",
"display": "C08CA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08CA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09DA04",
"display": "Irbesartan and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Irbesartan and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Irbesartan og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09DA",
"display": "Angiotensin II receptor blockers (ARBs) and diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09DA04",
"display": "C09DA04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09DA04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05AA08",
"display": "Fluocortolone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Fluocortolone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fluokortolon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05AA",
"display": "Corticosteroids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05AA08",
"display": "C05AA08"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05AA08"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02KX06",
"display": "Sotatercept",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Sotatercept"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Sotatercept"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02KX",
"display": "Antihypertensives for pulmonary arterial hypertension"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02KX06",
"display": "C02KX06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2024-07-10T00:00:00Z",
"display": "2024-07-10T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02KX06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03EA05",
"display": "Mebutizide and potassium-sparing agents",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Mebutizide and potassium-sparing agents"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Mebutizid og kaliumsparende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03EA",
"display": "Low-ceiling diuretics and potassium-sparing agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03EA05",
"display": "C03EA05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03EA05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AX06",
"display": "Omega-3-triglycerides incl. other esters and acids",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Omega-3-triglycerides incl. other esters and acids"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Omega-3-triglycerider inkl. andre estere og syrer"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AX",
"display": "Other lipid modifying agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AX06",
"display": "C10AX06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AX06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AD",
"display": "Purine derivatives",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Purine derivatives"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Purinderivater"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04A",
"display": "Peripheral vasodilators"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AD",
"display": "C04AD"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AD"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AX01",
"display": "Dextrothyroxine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Dextrothyroxine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Dekstrotyroksin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AX",
"display": "Other lipid modifying agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AX01",
"display": "C10AX01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AX01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08EX02",
"display": "Perhexiline",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Perhexiline"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Perheksilin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08EX",
"display": "Other non-selective calcium channel blockers"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08EX02",
"display": "C08EX02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08EX02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02CA",
"display": "Alpha-adrenoreceptor antagonists",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Alpha-adrenoreceptor antagonists"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Alfablokkere"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02C",
"display": "Antiadrenergic agents, peripherally acting"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02CA",
"display": "C02CA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02CA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05AX02",
"display": "Bismuth preparations, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bismuth preparations, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Vismutmidler, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05AX",
"display": "Other agents for treatment of hemorrhoids and anal fissures for topical use"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05AX02",
"display": "C05AX02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05AX02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05CA01",
"display": "Rutoside",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Rutoside"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Rutosid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05CA",
"display": "Bioflavonoids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05CA01",
"display": "C05CA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05CA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AX",
"display": "Other lipid modifying agents",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other lipid modifying agents"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre lipidmodifiserende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10A",
"display": "Lipid modifying agents, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AX",
"display": "C10AX"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AX"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01EB10",
"display": "Adenosine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Adenosine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Adenosin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01EB",
"display": "Other cardiac preparations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01EB10",
"display": "C01EB10"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01EB10"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01",
"display": "Cardiac therapy",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Cardiac therapy"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Hjerteterapi"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C",
"display": "Cardiovascular system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01",
"display": "C01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09BX04",
"display": "Perindopril, bisoprolol and amlodipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Perindopril, bisoprolol and amlodipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Perindopril, bisoprolol og amlodipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09BX",
"display": "ACE inhibitors, other combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09BX04",
"display": "C09BX04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2019-04-09T00:00:00Z",
"display": "2019-04-09T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09BX04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07BA12",
"display": "Nadolol and thiazides",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Nadolol and thiazides"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nadolol og tiazider"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07BA",
"display": "Beta blocking agents, non-selective, and thiazides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07BA12",
"display": "C07BA12"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07BA12"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07AA16",
"display": "Tertatolol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Tertatolol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tertatolol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07AA",
"display": "Beta blocking agents, non-selective"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07AA16",
"display": "C07AA16"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07AA16"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02DA01",
"display": "Diazoxide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Diazoxide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Diazoksid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02DA",
"display": "Thiazide derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02DA01",
"display": "C02DA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02DA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02LA71",
"display": "Reserpine and diuretics, combinations with psycholeptics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Reserpine and diuretics, combinations with psycholeptics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Reserpin og diuretika, kombinasjoner med psykoleptika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02LA",
"display": "Rauwolfia alkaloids and diuretics in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02LA71",
"display": "C02LA71"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02LA71"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DA07",
"display": "Propatylnitrate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Propatylnitrate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Propatylnitrat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DA",
"display": "Organic nitrates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DA07",
"display": "C01DA07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DA07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01BA04",
"display": "Sparteine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Sparteine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Spartein"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01BA",
"display": "Antiarrhythmics, class Ia"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01BA04",
"display": "C01BA04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01BA04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10B",
"display": "Lipid modifying agents, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Lipid modifying agents, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Lipidmodifiserende midler, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10",
"display": "Lipid modifying agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10B",
"display": "C10B"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10B"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07BA06",
"display": "Timolol and thiazides",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Timolol and thiazides"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Timolol og tiazider"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07BA",
"display": "Beta blocking agents, non-selective, and thiazides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07BA06",
"display": "C07BA06"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07BA06"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09BB02",
"display": "Enalapril and lercanidipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Enalapril and lercanidipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Enalapril og lerkanidipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09BB",
"display": "ACE inhibitors and calcium channel blockers"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09BB02",
"display": "C09BB02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09BB02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02KX05",
"display": "Riociguat",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Riociguat"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Riociguat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02KX",
"display": "Antihypertensives for pulmonary arterial hypertension"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02KX05",
"display": "C02KX05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2014-02-20T00:00:00Z",
"display": "2014-02-20T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02KX05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09DA10",
"display": "Fimasartan and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Fimasartan and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fimasartan og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09DA",
"display": "Angiotensin II receptor blockers (ARBs) and diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09DA10",
"display": "C09DA10"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2017-12-01T00:00:00Z",
"display": "2017-12-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09DA10"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03DA02",
"display": "Potassium canrenoate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Potassium canrenoate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kanrenoatkalium"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03DA",
"display": "Aldosterone antagonists"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03DA02",
"display": "C03DA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03DA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AA01",
"display": "Isoxsuprine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Isoxsuprine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Isoksuprin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04AA",
"display": "2-amino-1-phenylethanol derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AA01",
"display": "C04AA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02DD",
"display": "Nitroferricyanide derivatives",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Nitroferricyanide derivatives"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nitroferricyanidderivater"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02D",
"display": "Arteriolar smooth muscle, agents acting on"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02DD",
"display": "C02DD"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02DD"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03BA09",
"display": "Meticrane",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Meticrane"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Metikran"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03BA",
"display": "Sulfonamides, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03BA09",
"display": "C03BA09"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03BA09"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08C",
"display": "Selective calcium channel blockers with mainly vascular effects",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Selective calcium channel blockers with mainly vascular effects"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Selektive kalsiumantagonister med primært vaskulær virkning"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08",
"display": "Calcium channel blockers"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08C",
"display": "C08C"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08C"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08CA09",
"display": "Lacidipine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Lacidipine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Lacidipin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08CA",
"display": "Dihydropyridine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08CA09",
"display": "C08CA09"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08CA09"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BA02",
"display": "Simvastatin and ezetimibe",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Simvastatin and ezetimibe"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Simvastatin og ezetimib"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10BA",
"display": "Combinations of various lipid modifying agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BA02",
"display": "C10BA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2005-08-17T00:00:00Z",
"display": "2005-08-17T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02AA53",
"display": "Combinations of rauwolfia alkoloids, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Combinations of rauwolfia alkoloids, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Rauwolfiaalkaloider i blanding, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02AA",
"display": "Rauwolfia alkaloids"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02AA53",
"display": "C02AA53"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02AA53"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02KX54",
"display": "Macitentan and tadalafil",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Macitentan and tadalafil"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Makitentan og tadalafil"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02KX",
"display": "Antihypertensives for pulmonary arterial hypertension"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02KX54",
"display": "C02KX54"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2022-05-05T00:00:00Z",
"display": "2022-05-05T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02KX54"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07D",
"display": "Beta blocking agents, selective, thiazides and other diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Beta blocking agents, selective, thiazides and other diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Betablokkere, tiazider og andre diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07",
"display": "Beta blocking agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07D",
"display": "C07D"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07D"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02CC04",
"display": "Debrisoquine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Debrisoquine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Debrisokin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02CC",
"display": "Guanidine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02CC04",
"display": "C02CC04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02CC04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DA54",
"display": "Methylpropylpropanediol dinitrate, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Methylpropylpropanediol dinitrate, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Metylpropylpropandioldinitrat, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DA",
"display": "Organic nitrates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DA54",
"display": "C01DA54"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DA54"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02B",
"display": "Antiadrenergic agents, ganglion-blocking",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Antiadrenergic agents, ganglion-blocking"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Antiadrenergika, ganglieblokkerende"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02",
"display": "Antihypertensives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02B",
"display": "C02B"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02B"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03AH",
"display": "Thiazides, combinations with psycholeptics and/or analgesics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Thiazides, combinations with psycholeptics and/or analgesics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tiazider, kombinasjoner med psykoleptika og/eller analgetika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03A",
"display": "Low-ceiling diuretics, thiazides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03AH",
"display": "C03AH"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03AH"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03DA",
"display": "Aldosterone antagonists",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Aldosterone antagonists"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Aldosteronantagonister"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03D",
"display": "Aldosterone antagonists and other potassium-sparing agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03DA",
"display": "C03DA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03DA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AX02",
"display": "Probucol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Probucol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Probukol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AX",
"display": "Other lipid modifying agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AX02",
"display": "C10AX02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AX02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09AA09",
"display": "Fosinopril",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Fosinopril"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Fosinopril"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09AA",
"display": "ACE inhibitors, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09AA09",
"display": "C09AA09"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09AA09"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09AA08",
"display": "Cilazapril",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Cilazapril"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Cilazapril"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09AA",
"display": "ACE inhibitors, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09AA08",
"display": "C09AA08"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09AA08"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05AE03",
"display": "Diltiazem",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Diltiazem"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Diltiazem"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05AE",
"display": "Muscle relaxants"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05AE03",
"display": "C05AE03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2014-02-20T00:00:00Z",
"display": "2014-02-20T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05AE03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02KX",
"display": "Antihypertensives for pulmonary arterial hypertension",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Antihypertensives for pulmonary arterial hypertension"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Antihypertensiva for pulmonal arteriell hypertensjon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02K",
"display": "Other antihypertensives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02KX",
"display": "C02KX"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02KX"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03BC",
"display": "Mercurial diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Mercurial diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kvikksølvdiuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03B",
"display": "Low-ceiling diuretics, excl. thiazides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03BC",
"display": "C03BC"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03BC"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AB09",
"display": "Etofibrate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Etofibrate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Etofibrat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AB",
"display": "Fibrates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AB09",
"display": "C10AB09"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AB09"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10AB11",
"display": "Choline fenofibrate",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Choline fenofibrate"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kolinfenofibrat"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10AB",
"display": "Fibrates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10AB11",
"display": "C10AB11"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2011-01-01T00:00:00Z",
"display": "2011-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10AB11"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02LA52",
"display": "Rescinnamine and diuretics, combinations with other drugs",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Rescinnamine and diuretics, combinations with other drugs"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Reskinnamin og diuretika, kombinasjoner med andre midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02LA",
"display": "Rauwolfia alkaloids and diuretics in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02LA52",
"display": "C02LA52"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02LA52"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01EB22",
"display": "Meldonium",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Meldonium"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Meldonium"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01EB",
"display": "Other cardiac preparations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01EB22",
"display": "C01EB22"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2013-12-10T00:00:00Z",
"display": "2013-12-10T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01EB22"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07AA12",
"display": "Nadolol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Nadolol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Nadolol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07AA",
"display": "Beta blocking agents, non-selective"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07AA12",
"display": "C07AA12"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07AA12"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07BB03",
"display": "Atenolol and thiazides",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Atenolol and thiazides"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Atenolol og tiazider"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07BB",
"display": "Beta blocking agents, selective, and thiazides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07BB03",
"display": "C07BB03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07BB03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03BB02",
"display": "Quinethazone and potassium",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Quinethazone and potassium"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Kinetazon og kalium"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03BB",
"display": "Sulfonamides and potassium in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03BB02",
"display": "C03BB02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03BB02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02BB",
"display": "Secondary and tertiary amines",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Secondary and tertiary amines"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Sekundære og tertiære aminer"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02B",
"display": "Antiadrenergic agents, ganglion-blocking"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02BB",
"display": "C02BB"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02BB"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09XA02",
"display": "Aliskiren",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Aliskiren"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Aliskiren"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09XA",
"display": "Renin-inhibitors"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09XA02",
"display": "C09XA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2007-01-01T00:00:00Z",
"display": "2007-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09XA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02KX03",
"display": "Sitaxentan",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Sitaxentan"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Sitaksentan"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02KX",
"display": "Antihypertensives for pulmonary arterial hypertension"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02KX03",
"display": "C02KX03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2008-01-01T00:00:00Z",
"display": "2008-01-01T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02KX03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04A",
"display": "Peripheral vasodilators",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Peripheral vasodilators"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Perifere kardilaterende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04",
"display": "Peripheral vasodilators"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04A",
"display": "C04A"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04A"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DX09",
"display": "Imolamine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Imolamine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Imolamin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DX",
"display": "Other vasodilators used in cardiac diseases"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DX09",
"display": "C01DX09"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DX09"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07AA02",
"display": "Oxprenolol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Oxprenolol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Oksprenolol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07AA",
"display": "Beta blocking agents, non-selective"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07AA02",
"display": "C07AA02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07AA02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01E",
"display": "Other cardiac preparations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other cardiac preparations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre midler for hjerteterapi"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01",
"display": "Cardiac therapy"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01E",
"display": "C01E"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01E"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01EB16",
"display": "Ibuprofen",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Ibuprofen"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ibuprofen"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01EB",
"display": "Other cardiac preparations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01EB16",
"display": "C01EB16"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2007-03-04T00:00:00Z",
"display": "2007-03-04T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01EB16"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03CB02",
"display": "Bumetanide and potassium",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bumetanide and potassium"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Bumetanid og kalium"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03CB",
"display": "Sulfonamides and potassium in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03CB02",
"display": "C03CB02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03CB02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02AA",
"display": "Rauwolfia alkaloids",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Rauwolfia alkaloids"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Rauwolfiaalkaloider"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02A",
"display": "Antiadrenergic agents, centrally acting"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02AA",
"display": "C02AA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02AA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03BA03",
"display": "Clopamide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Clopamide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Klopamid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03BA",
"display": "Sulfonamides, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03BA03",
"display": "C03BA03"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03BA03"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02BC",
"display": "Bisquaternary ammonium compounds",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Bisquaternary ammonium compounds"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Biskvartære ammoniumforbindelser"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02B",
"display": "Antiadrenergic agents, ganglion-blocking"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02BC",
"display": "C02BC"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02BC"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09DX08",
"display": "Telmisartan, amlodipine and hydrochlorothiazide",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Telmisartan, amlodipine and hydrochlorothiazide"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Telmisartan, amlodipin og hydroklortiazid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09DX",
"display": "Angiotensin II receptor blockers (ARBs), other combinations"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09DX08",
"display": "C09DX08"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2022-05-05T00:00:00Z",
"display": "2022-05-05T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09DX08"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C05CX01",
"display": "Tribenoside",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Tribenoside"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tribenosid"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C05CX",
"display": "Other capillary stabilizing agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C05CX01",
"display": "C05CX01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C05CX01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02CC01",
"display": "Betanidine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Betanidine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Betanidin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02CC",
"display": "Guanidine derivatives"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02CC01",
"display": "C02CC01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02CC01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DA38",
"display": "Tenitramine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Tenitramine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Tenitramin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DA",
"display": "Organic nitrates"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DA38",
"display": "C01DA38"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DA38"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07CG",
"display": "Alpha and beta blocking agents and other diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Alpha and beta blocking agents and other diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Alfa- og betablokkere og andre diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07C",
"display": "Beta blocking agents and other diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07CG",
"display": "C07CG"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07CG"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03DA01",
"display": "Spironolactone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Spironolactone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Spironolakton"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03DA",
"display": "Aldosterone antagonists"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03DA01",
"display": "C03DA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03DA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03EA12",
"display": "Metolazone and potassium-sparing agents",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Metolazone and potassium-sparing agents"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Metolazon og kaliumsparende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03EA",
"display": "Low-ceiling diuretics and potassium-sparing agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03EA12",
"display": "C03EA12"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03EA12"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C10BX18",
"display": "Atorvastatin, amlodipine and ramipril",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Atorvastatin, amlodipine and ramipril"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Atorvastatin, amlodipin og ramipril"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C10BX",
"display": "Lipid modifying agents in combination with other drugs"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C10BX18",
"display": "C10BX18"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2020-10-12T00:00:00Z",
"display": "2020-10-12T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C10BX18"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01AA01",
"display": "Acetyldigitoxin",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Acetyldigitoxin"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Acetyldigitoksin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01AA",
"display": "Digitalis glycosides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01AA01",
"display": "C01AA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01AA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03BX",
"display": "Other low-ceiling diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Other low-ceiling diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Andre diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03B",
"display": "Low-ceiling diuretics, excl. thiazides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03BX",
"display": "C03BX"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03BX"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07AG02",
"display": "Carvedilol",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Carvedilol"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Karvedilol"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07AG",
"display": "Alpha and beta blocking agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07AG02",
"display": "C07AG02"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07AG02"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01CA05",
"display": "Norfenefrine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Norfenefrine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Norfenefrin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01CA",
"display": "Adrenergic and dopaminergic agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01CA05",
"display": "C01CA05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01CA05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07E",
"display": "Beta blocking agents and vasodilators",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Beta blocking agents and vasodilators"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Betablokkere og vasodilaterende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07",
"display": "Beta blocking agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07E",
"display": "C07E"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07E"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03BA04",
"display": "Chlortalidone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Chlortalidone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Klortalidon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03BA",
"display": "Sulfonamides, plain"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03BA04",
"display": "C03BA04"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03BA04"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09BA13",
"display": "Moexipril and diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Moexipril and diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Moeksipril og diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09BA",
"display": "ACE inhibitors and diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09BA13",
"display": "C09BA13"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09BA13"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07DA",
"display": "Beta blocking agents, non-selective, thiazides and other diuretics",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Beta blocking agents, non-selective, thiazides and other diuretics"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Betablokker, ikke-selektiv, tiazider andre diuretika"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07D",
"display": "Beta blocking agents, selective, thiazides and other diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07DA",
"display": "C07DA"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07DA"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03DA05",
"display": "Finerenone",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Finerenone"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Finerenon"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03DA",
"display": "Aldosterone antagonists"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03DA05",
"display": "C03DA05"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2021-11-08T00:00:00Z",
"display": "2021-11-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03DA05"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C07BA68",
"display": "Metipranolol and thiazides, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Metipranolol and thiazides, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Metipranolol og tiazider, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C07BA",
"display": "Beta blocking agents, non-selective, and thiazides"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C07BA68",
"display": "C07BA68"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C07BA68"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C08E",
"display": "Non-selective calcium channel blockers",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Non-selective calcium channel blockers"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Ikke-selektive kalsiumantagonister"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C08",
"display": "Calcium channel blockers"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C08E",
"display": "C08E"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C08E"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03EA14",
"display": "Butizide and potassium-sparing agents",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Butizide and potassium-sparing agents"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Butizid og kaliumsparende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03EA",
"display": "Low-ceiling diuretics and potassium-sparing agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03EA14",
"display": "C03EA14"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03EA14"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C02LA50",
"display": "Comb. of rauwolfia alkaloids and diuretics incl. other combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Comb. of rauwolfia alkaloids and diuretics incl. other combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Rauwolfiaalkaolider i blanding og diuretika inkl. andre kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C02LA",
"display": "Rauwolfia alkaloids and diuretics in combination"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C02LA50",
"display": "C02LA50"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C02LA50"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01DX51",
"display": "Itramin tosilate, combinations",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Itramin tosilate, combinations"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Itramintosilat, kombinasjoner"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01DX",
"display": "Other vasodilators used in cardiac diseases"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01DX51",
"display": "C01DX51"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01DX51"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03B",
"display": "Low-ceiling diuretics, excl. thiazides",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Low-ceiling diuretics, excl. thiazides"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Low-ceiling diuretika, ekskl. tiazider"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03",
"display": "Diuretics"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03B",
"display": "C03B"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03B"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C01BB",
"display": "Antiarrhythmics, class Ib",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Antiarrhythmics, class Ib"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Antiarytmika, klasse Ib"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C01B",
"display": "Antiarrhythmics, class I and III"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C01BB",
"display": "C01BB"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C01BB"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C03EA01",
"display": "Hydrochlorothiazide and potassium-sparing agents",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Hydrochlorothiazide and potassium-sparing agents"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Hydroklortiazid og kaliumsparende midler"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C03EA",
"display": "Low-ceiling diuretics and potassium-sparing agents"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C03EA01",
"display": "C03EA01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C03EA01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C04AX07",
"display": "Vincamine",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Vincamine"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Vinkamin"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C04AX",
"display": "Other peripheral vasodilators"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C04AX07",
"display": "C04AX07"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2002-02-08T00:00:00Z",
"display": "2002-02-08T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C04AX07"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
},
{
"code": "C09XX01",
"display": "Sparsentan",
"designation": [
{
"language": "en",
"use": {
"code": "term-name"
},
"value": "Sparsentan"
},
{
"language": "no",
"use": {
"code": "term-name"
},
"value": "Sparsentan"
}
],
"property": [
{
"code": "parentATC",
"valueCoding": {
"system": "https://api.legemiddelverket.no/FHIR-R4/CodeSystem/e104a7eb-e832-4d57-946d-d402b71ecc22",
"code": "C09XX",
"display": "Other agents acting on the renin-angiotensin system"
}
},
{
"code": "ATCCode",
"valueCoding": {
"code": "C09XX01",
"display": "C09XX01"
}
},
{
"code": "fromDate",
"valueCoding": {
"code": "2024-07-29T00:00:00Z",
"display": "2024-07-29T00:00:00Z"
}
},
{
"code": "internalCode",
"valueCoding": {
"code": "C09XX01"
}
},
{
"code": "internalTermStatus",
"valueCoding": {
"code": "Godkjent WHO",
"display": "Godkjent WHO"
}
}
]
}
]
}